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Abstract 
Harmful substance use is a prevalent and under-treated public health problem, with use of 
alcohol, tobacco, and illicit drugs among the top preventable causes of death in the United States. 
The unmet need for treatment is particularly pronounced among young adults, for whom 
university primary care is an important venue for early detection and intervention. Although a 
number of different multi-substance use screens have been developed for primary care settings, 
none have been validated in university primary care. Other behavioral health concerns are also 
highly prevalent among college students, although little is known regarding how behavioral risk 
factors co-occur in this setting. Accordingly, this study aimed to extend research on the validity 
of the 4-item Substance Use Brief Screen (SUBS) in a university primary care setting. The 
diagnostic utility of the SUBS was also compared to an established screen for at-risk drinking, 
the Alcohol Use Disorder Identification Test – Consumption (AUDIT-C). Finally, this study 
described prevalence rates and identified cluster profiles of multiple risk factors, including at-
risk substance use, behavioral health concerns, and body mass index. Participants (n = 100) were 
recruited from Syracuse University Health Services to complete self-report screens and a 
structured interview. Results support the construct validity and utility of the SUBS in university 
primary care, with cut-off scores of 1 for tobacco and nonmedical prescription drug use, and 2 
for at-risk alcohol and illicit drug use. Results also suggest that behavioral health risk factors 
commonly co-occur, thereby supporting the development of brief, combined interventions 
targeting multiple risk factors in university primary care. 
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Screening for At-Risk Substance Use and Behavioral Health Concerns in University Primary 
Care 
 Harmful substance use is a prevalent and under-treated public health problem, with use of 
alcohol, tobacco, and illicit drugs among the top preventable causes of death in the United States 
(Mokdad, Marks, Stroup, & Gerberding, 2004). It is estimated that over 20 million individuals in 
the U.S. meet criteria for Substance Use Disorder (SUD), of whom only a small percentage 
receive substance use treatment (i.e., 10.8% in 2015; Lipari, Park-Lee, & Van Horn, 2016). The 
unmet need for treatment is particularly pronounced among young adults aged 18-25, of whom 1 
in 6 meet criteria for SUD (Lipari et al., 2016). Past-year use among young adults is especially 
prevalent for alcohol (75.5%), tobacco (43.8%), cannabis (32.2%), and nonmedical use of 
prescription medications (15.3%), particularly opioids and stimulants (Center for Behavioral 
Health Statistics and Quality, 2016). Despite the significant health consequences of SUD (Brick, 
2008), the vast majority (97%) of young adults with untreated SUD do not perceive themselves 
as needing treatment (Lipari et al., 2016). Given that approximately 40% of young adults in the 
United States attend college (National Center for Education Statistics, 2019), and the majority of 
young adults with SUD do not seek or perceive a need for treatment, university primary care is 
an important venue for early detection and intervention for at-risk substance use among college 
students (Alschuler, Hoodin, & Byrd, 2008; Anderson et al., 2010).  
Integrated Primary Care 
 The practice of integrating screening and brief intervention for behavioral health 
concerns in primary care settings is known as integrated primary care (Pomerantz & Sayers, 
2010; Strosahl, 1998). Screening in university primary care provides an opportunity to identify 
behavioral health concerns that may otherwise go untreated, as fewer barriers exist for students 
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seeking treatment for physical health in comparison to mental health or other specialty services 
(Eisenberg, Golberstein, & Gollust, 2007). Integrated primary care also allows for more 
collaborative, efficient, and comprehensive treatment (deGruy & Etz, 2010). 
Screening and Brief Intervention in Primary Care 
 Although integrated primary care provides opportunities for early assessment and 
intervention, it also presents unique constraints. In particular, primary care providers are 
expected to assess for multiple health problems within a fifteen-minute appointment (Blumenthal 
et al., 1999; Gottschalk & Flocke, 2005; Tai-Seale & McGuire, 2012). Thus, thorough 
assessments of multiple behavioral health concerns are not feasible, and providers must 
determine priority areas in practice. Brief screens address this constraint by identifying 
potentially problematic behaviors and drawing attention to the need for further assessment or 
referral. Accordingly, it is important to keep screens as brief as possible within primary care 
settings so they can be completed, scored, and reviewed without taking too much time away 
from the presenting problem (Funderburk, Fielder, DeMartini, & Flynn, 2012). 
Although even the briefest of screens adds to the length of a primary care visit, 
behavioral health screens are important in that they function as an alert and call to action for 
further assessment. Screening measures also systematically call patients’ and providers’ attention 
to potential behavioral health concerns that may not otherwise be addressed due to time 
constraints and the decreased likelihood of addressing additional topics as time passes during the 
appointment (Tai-Seale & McGuire, 2012). This is consistent with preliminary research on 
patients’ and providers’ perceptions of behavioral health screens in university primary care, 
which revealed that using the screens led to an increased recognition and discussion of 
behavioral health concerns (Alschuler et al., 2008).  Likewise, a study of students’ experiences 
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with integrated behavioral health providers in University Health Services (UHS) showed that the 
majority (86%) of students who remembered completing a screening measure also talked to their 
provider about one or more behavioral health concerns addressed in the screen (Funderburk et 
al., 2012). 
 There is a strong evidence base for the utility of screening and brief intervention for 
reducing tobacco and alcohol use in primary care settings, and more recent research supports 
screening for other substances, as well (Babor et al., 2007; Pilowsky & Wu, 2012). Changes to 
insurance policies enacted with the Patient Protection and Affordable Care Act (ACA; 2010) 
offer an incentive to integrate preventive screening and treatment for SUD in the context of 
primary care. Likewise, a recent Surgeon General’s report recommended screening for SUD in 
primary care, likening the course of SUD to other chronic illnesses routinely treated and 
managed in primary care settings (U.S. Department of Health & Human Services, Office of the 
Surgeon General, 2016). Given this recommendation and the context of the ACA, screening for 
at-risk substance use in primary care seems increasingly relevant and feasible. Accordingly, there 
is a need for substance use screening instruments that are designed and validated for use in 
primary care settings. 
Multi-Substance Use Screens in Primary Care 
 In recent years, a number of different multi-substance use screens have been developed 
for primary care settings (e.g., Ali, Meena, Eastwood, Richards, & Marsden, 2013; Lanier & Ko, 
2008; McNeely, Cleland, et al., 2015; McNeely, Strauss, et al., 2015; McNeely et al., 2016; 
McPherson & Hersch, 2000; Tiet et al., 2015; Tiet, Leyva, Moos, & Smith, 2017, 2016). Some 
of these screens have limited utility for routine use in busy primary care settings because they are 
too lengthy (Ali et al., 2013; Kirisci, Reynolds, Carver, & Tarter, 2013; McNeely et al., 2016), 
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too narrow in focus such that they only screen for illicit drugs but not alcohol or nonmedical 
prescription drug use (Tiet et al., 2015, 2017, 2016), or validated to detect risk for SUD but not 
lower levels of at-risk substance use (Kirisci et al., 2013; McNeely & Saitz, 2015; Tiet et al., 
2015). Importantly, none of these recently developed screens have been validated in university 
primary care.  
 The Substance Use Brief Screen. The Substance Use Brief Screen (SUBS; McNeely, 
Strauss, et al., 2015) is particularly promising because it is brief (i.e., 4 items), self-administered, 
and developed to detect “unhealthy” alcohol, tobacco, illicit drug, and nonmedical prescription 
drug use during the past 12 months (see Appendix A). Unhealthy use is defined as meeting 
criteria for at-risk use according to a combination of reference standards, including moderate- or 
high-risk use on the Alcohol Smoking and Substance Involvement Screening Test (ASSIST; Ali 
et al., 2002; Humeniuk & World Health Organization, 2010) and the Timeline Followback 
(Sobell, Maisto, Sobell, & Cooper, 1979; Sobell & Sobell, 1992). Response options are “never,” 
“one to two days,” or “three or more days” in the past 12 months. For each item, endorsing any 
response except “never” counts as a positive screen for that specific substance. The tobacco, 
illicit drug, and nonmedical prescription drug use items assess frequency of any use. The alcohol 
item is designed to measure frequency of consuming four or more standard drinks in one day. 
Thus, having four or more drinks in a day, or using any tobacco, illicit drugs, or nonmedical 
prescriptions drugs during the past year would result in a positive screen. 
 The SUBS was initially validated among adults presenting to primary care in two large 
hospitals in New York City and Boston (McNeely, Strauss, et al., 2015). Subsequent research 
among hospitalized adults (Han, Sherman, Link, Wang, & McNeely, 2017) showed that the 
SUBS is a valid alternative to the AUDIT-C (Bradley et al., 2007; Bush, Kivlahan, McDonell, 
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Fihn, & Bradley, 1998) and the ASSIST (Ali et al., 2002; Humeniuk & World Health 
Organization, 2010). This is promising, as the 3-item AUDIT-C is limited by its exclusive focus 
on alcohol, and the interviewer-administered ASSIST is too involved and lengthy to fit into 
clinical workflows (Ali et al., 2013). Specifically, the ASSIST requires the provider to conduct 
an interview lasting up to 15 minutes, as well as provide feedback and/or referrals depending on 
the patient’s level of use. Despite the benefits of the brevity of the SUBS, and although the 
sensitivity for the SUBS detecting at-risk drinking was high among hospitalized adults (.98), its 
specificity was relatively low (.61; Han et al., 2017). A specificity (a.k.a. true negative rate) of 
.61 means that only 61% of individuals who do not meet the criterion of interest (i.e., at-risk 
drinking) are identified correctly as such. Therefore, the remaining 39% of individuals who 
would not meet the at-risk drinking criterion upon further assessment would be incorrectly 
flagged as positive by the initial screen. As a consequence of this elevated false positive rate, 
screening with one at-risk drinking item on the SUBS may place unnecessary burden on health 
care providers (Han et al., 2017).  
 It should be noted that the SUBS has not been validated in university primary care, and 
accordingly the sensitivity and specificity of the SUBS is unknown in that setting. In fact, few 
screens have been validated for detecting at-risk substance use in university primary care. One 
exception is the AUDIT-C (Campbell & Maisto, 2018). Relative to the SUBS (in hospitalized 
adults), the AUDIT-C is somewhat less sensitive and more specific in detecting at-risk drinking 
in students presenting to university primary care. Specifically, the AUDIT-C demonstrated 
sensitivity of .90 for females (.95 for males) and specificity of .77 for females (.81 for males; 
(Campbell & Maisto, 2018). Greater specificity indicates that a screen has fewer false positives, 
which is desirable in primary care settings where time and resources are limited. Considering the 
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need for providers to judiciously allocate their limited time with each patient (Tai-Seale & 
McGuire, 2012), further research is needed comparing the SUBS to other established screens for 
at-risk drinking (i.e., the AUDIT-C), with an eye toward maximizing specificity and thereby 
minimizing false positives. 
 Despite the benefits of its potentially greater specificity, the AUDIT-C may have less 
clinical utility than the SUBS because the AUDIT-C does not detect other problematic substance 
use, also prevalent among college students (Johnston, O’Malley, Bachman, Schulenberg, & 
Miech, 2016). When deciding on which screen(s) to implement, primary care providers should 
consider both sensitivity and specificity, as well as the clinical utility of the screening instrument. 
For instance, if sensitivity and specificity are comparable, a 4-item screen for four separate 
substances (e.g., SUBS) would be more clinically informative than a 3-item screen for one 
substance (e.g., AUDIT-C).  
 One additional limitation of the SUBS is that it does not directly screen for concurrent 
use of multiple substances. This is important, particularly for college students, because research 
suggests that young adults experience elevated negative consequences when substances are used 
concurrently (e.g., simultaneous alcohol and marijuana use; (Agosti, Nunes, & Levin, 2002). The 
co-occurrence of marijuana and alcohol during adolescence and young adulthood in particular is 
uniquely associated with impairments in subsequent brain development (Jacobus, Squeglia, 
Meruelo, et al., 2015), cognitive functioning (Jacobus, Squeglia, Infante, et al., 2015), and 
academic performance (Meda et al., 2017). This limitation could be remedied by adding one 
additional item to the SUBS assessing concurrent use of multiple substances. 
Additional Behavioral Health Screening 
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 In addition to substance use, other behavioral health concerns are highly prevalent among 
college students. A recent national survey shows that 15% to 30% of college students endorse 
elevated anxiety, depression, sleep difficulties, and/or stress that impairs their academic 
performance (American College Health Association, 2016). Data from the American College 
Health Association national survey suggests that these behavioral health problems commonly co-
occur, such that 10.9% of students endorse both depression and anxiety during the past year, and 
7.7% endorse a combination of two or more other behavioral health concerns.  
 One study on behavioral health screening at Syracuse UHS provides information 
regarding the prevalence of positive screens in the context of university primary care 
(Shepardson & Funderburk, 2014). During the Spring 2010 semester, 38.3% of students screened 
positive for at-risk alcohol use, 13.3% endorsed sleep problems, 9.5% endorsed wanting to talk 
to someone about smoking cessation, 9.1% screened positive for depression, and 2.5% endorsed 
suicidal ideation (Shepardson & Funderburk, 2014). Other behavioral health concerns were not 
assessed (e.g., anxiety, trauma, abuse of prescription medications, cannabis, or other drugs). 
Although these prevalence data are helpful for describing risk factors for students presenting to 
university primary care, little is known regarding how these risk factors co-occur in this setting. 
Likewise, the American College Health Association national survey (2016) does not report 
prevalence data regarding how specific problems co-occur, with the exception of depression and 
anxiety. 
 Accordingly, research is needed regarding the co-occurrence of positive screens in 
university primary care. Prevalence data on the co-occurrence of positive screens has the 
potential to inform the development of integrated treatments in university primary care settings, 
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which may ultimately improve the efficiency and cost effectiveness of behavioral health 
interventions (J. J. Prochaska, Spring, & Nigg, 2008; J. O. Prochaska, 2008).    
 Much of the research on co-occurring risk factors has focused on the four leading 
contributors to preventable disease and mortality in the United States: at-risk drinking, tobacco 
use, physical inactivity, and unhealthy diet (Babor, Sciamanna, & Pronk, 2004). These risk 
factors tend to co-occur, such that a slight majority (52%) of U.S. adults in primary care report 
two or more (Coups, Gaba, & Orleans, 2004). There is also evidence that certain risk factors tend 
to co-occur according to identifiable patterns, or clusters, and that these clusters can predict 
future healthcare utilization (Funderburk, Maisto, & Labbe, 2014; Funderburk, Maisto, 
Sugarman, & Wade, 2008). Few studies have examined how these risk factors cluster together in 
college student samples in the United States (e.g., Kang et al., 2014; Quintiliani, Allen, Marino, 
Kelly-Weeder, & Li, 2010), none of which have examined co-occurrence as indicated by positive 
screens in primary care settings. 
Study Aims 
 This review has shown that the Substance Use Brief Screen (SUBS) does not have 
empirically demonstrated utility among college students presenting to university primary care. In 
fact, no multi-substance use screen has been validated in university primary care. Furthermore, it 
would be informative to compare the diagnostic utility of the SUBS to previously validated 
screens in the university primary care setting. Finally, no prior research in the United States has 
described the co-occurrence and clustering of behavioral risk factors among students utilizing 
university primary care.  
The primary aim of this study was to replicate and extend research on the validity of the 
SUBS (McNeely, Strauss, et al., 2015) when used in a university primary care setting. Bivariate 
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correlations and Receiver Operating Characteristic (ROC) curve analyses tested the construct 
validity and utility of the SUBS for detecting at-risk drinking, and at-risk use of tobacco, illicit 
drugs, nonmedical prescription drugs, and concurrent multiple substance use (Metz, 1978). It 
was hypothesized that the SUBS item for each class of substance would be positively correlated 
with its respective score on the ASSIST. It was also expected that the SUBS would perform 
significantly better than chance in detecting at-risk substance use, as indicated by ROC curve 
analyses. Regarding optimal cut-off scores, prior research indicates that higher cut-off scores are 
recommended for college students relative to community samples of adults (Campbell & Maisto, 
2018; DeMartini & Carey, 2012; Kelly, Donovan, Chung, Bukstein, & Cornelius, 2009). Lower 
levels of substance use, as indicated by the cut-off of 1 on the SUBS, may be less risky among 
college students for a number of reasons, including fewer responsibilities and obligations (e.g., 
family, employment) and protective factors that make the college environment safer relative to 
substance use outside the confines of college life (Colby, Colby, & Raymond, 2009). Research 
on drinking norms also suggests that heavy drinking is perceived as less harmful among young 
adult college students relative to older, employed adults (Colby, Swanton, & Colby, 2012) and 
that college students who moderate their drinking may in fact experience negative social 
consequences (Robertson & Tustin, 2018). Accordingly, it was hypothesized that at-risk 
substance use, as indicated by the ASSIST, would be best predicted by a cut-off score of 2 on the 
SUBS. 
 A secondary aim of this study was to compare the utility of the SUBS alcohol item to the 
AUDIT-C in detecting at-risk drinking. Diagnostic indices of the SUBS alcohol item were 
compared to those of the AUDIT-C. The practical benefit of a 1-item alcohol screen (SUBS) in 
comparison to a 3-item screen (AUDIT-C) was also considered to inform clinical practice. 
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 A third, exploratory aim was to describe prevalence rates and identify cluster profiles of 
multiple risk factors in university primary care. Brief screens were used to identify the following 
risk factors: substance use (at-risk alcohol, tobacco, illicit drug, and nonmedical prescription 
drug use), mental health problems (anxiety, depression, sleep difficulties, posttraumatic stress, 
and suicidal ideation), and a proxy for other lifestyle factors (BMI). Cluster analyses were 
conducted to describe whether and how these risk factors cluster together.  
Methods 
Study Procedures 
 Data collection began in February 2018 and concluded in June 2018. All students age 18 
or older presenting for any type of medical care at UHS were eligible to participate. Patients 
were recruited from the UHS waiting room by research assistants seated at a table near the 
entrance. Information sheets describing the study were also placed at check-in stations and 
throughout the waiting room. Research assistants introduced the study by offering patients the 
option to participate in a research study about students’ health behaviors, including substance 
use, and emphasizing that the information would be for research purposes only and would not be 
discussed with providers or anyone else outside the research team. Patients were given the option 
to sign up for a research session at a specified time or to provide their email address so that they 
could be sent a link to schedule a research session at another time that was convenient to them. 
This contact information was used solely for recruitment and was not tied in any way to 
participant data. Patients were encouraged to schedule for same-day research sessions, when 
available. 
 Upon presenting to their research session, participants completed informed consent, 
followed by the ASSIST interview, had their height/weight measured, and completed a battery of 
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screening measures. Study procedures, excluding informed consent, lasted an average of 22 
minutes per participant (m = 21.91, SD = 6.24).  
Compensation. For purposes of compensation, participants were invited to provide an 
email address after they completed the study procedures. Email addresses were added to a 
database kept separate from any participant data. Email addresses were solely used for 
compensation and were not linked to any participant data or other identifying information.  
The first 21 participants were entered into a prize drawing for one of ten $100 gift cards. 
After five weeks of data collection, additional compensation was added to improve recruitment 
rates. The remaining 79 participants were each compensated with a $10 e-gift card and were also 
entered into the prize drawing so that the odds of winning were consistent across all participants. 
The prize drawing occurred upon the study’s completion.  
 Debriefing and referrals. After completing all study procedures, participants were 
debriefed and offered referral information for on-campus and community resources. Students 
who screened positive for suicidal ideation were offered a suicide risk assessment completed by 
a graduate student clinician under the supervision of a licensed clinical psychologist. Protocols 
were in place so that students endorsing current suicidal ideation with intent or plan would 
immediately be connected to the Syracuse University Counseling Center for crisis services. No 
participants required an immediate referral for crisis services.  
 Participants. A sample of 100 students was recruited for the study. See Table 1 for 
demographic information. The sample was predominantly female (76.8%). The average age was 
23.3 years, and 43% were graduate students. Most (70%) were not involved in Greek life, and 
67% spoke English as their first language. Identified race was 43% White, 34% Asian, 10% 
Multi-racial, 8% Black, and 5% Other. Twelve percent of participants identified as Hispanic.  
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To provide context for the setting in which the study occurred, the university student 
population is approximately 55% female, 75% white, with a mean age of 21 years old (Syracuse 
University, 2016). As of 2016, the university consisted of 25% graduate students, and the 
remaining 75% of undergraduates were a relatively even distribution of freshmen, sophomores, 
juniors, and seniors. 
To further examine representativeness of data, unpublished and de-identified data were 
obtained from UHS regarding demographics of patients seen at UHS during the Fall 2017 
semester; data were not available for the Spring 2018 semester. Compared to the demographics 
of students seen at UHS, the current study sample included a greater proportion of students 
identifying as female (77% vs. 61%), Asian (34% vs. 25%) and graduate students (43% vs. 
22%). The study sample was also somewhat older (m = 23.32, SD = 5.56) on average, than the 
typical student seen at UHS (m = 21.43, SD = 4.06). Although the UHS data from Fall 2017 did 
not include information on ESL status, it is known that 28% of those patients were international 
students from outside the United States. This approximates the 33% of students in the current 
study who identified English as a second language. 
Measures (See Appendices) 
Substance Use Brief Screen. The Substance Use Brief Screen (SUBS; McNeely, 
Strauss, et al., 2015) is a 4-item, self-administered screen developed to detect past-year at-risk 
alcohol, tobacco, illicit drug, and nonmedical prescription drug use. Response options are 
“never,” “one to two days,” or “three or more days” in the past 12 months. For each item, 
endorsing any response except “never” counts as a positive screen for that specific substance. 
The tobacco, illicit drug, and nonmedical prescription drug use items assess frequency of any 
use. The alcohol item is designed to measure frequency of consuming 4 or more standard drinks 
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in one day. Initial research suggests the SUBS has good test-retest reliability, construct validity, 
and feasibility in primary care settings (McNeely, Strauss, et al., 2015). For the present study, an 
additional item was added to the SUBS to screen for concurrent use of multiple substances (see 
Appendix B). 
Substance use reference standard. The Alcohol, Smoking and Substance Involvement 
Screening Test (ASSIST; Ali et al., 2002; Humeniuk & World Health Organization, 2010) is a 
structured interview that served as a reference standard for determining whether participants met 
criteria for at-risk substance use (i.e., at-risk use of alcohol, tobacco, illicit drugs, and 
nonmedical prescription drugs). At-risk use was defined by a score of 11 or more for alcohol and 
a score of 4 or more for all other substances (Humeniuk & World Health Organization, 2010). 
The ASSIST consists of eight questions, the first of which queries for lifetime substance use, 
followed by six questions about substance-related problems for each endorsed substance (i.e., 
questions 2 through 7), and a final question about injection drug use. Questions 2 through 7 are 
summed to create an ASSIST score for each class of substance, also referred to as the substance 
involvement score (Humeniuk, Ali, & WHO ASSIST Phase II Study Group, 2006; Humeniuk & 
World Health Organization, 2010). Item 5, which indicates failure to do what is normally 
expected of you, is excluded from the tobacco ASSIST score (Humeniuk & World Health 
Organization, 2010). Among adults in primary care and specialty treatment settings, the ASSIST 
has demonstrated strong test-retest reliability and internal consistency, as well as strong 
concurrent, predictive, discriminative, and construct validity (Humeniuk et al., 2006; McNeely et 
al., 2014; WHO ASSIST Working Group, 2002). Consistent with prior research screening for 
nonmedical use of prescription drugs, two classes of substances were added to the ASSIST: 
prescription opioids and prescription stimulants (Han et al., 2017; McNeely et al., 2014, 2016). 
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This addition is also consistent with the NIDA-modified ASSIST (National Institute on Drug 
Abuse, 2009). For purposes of differentiating between prescription and non-prescription drugs, 
the current study also added a class of substances for prescription sedatives. Lastly, in order to 
correspond with the time frame referenced on the SUBS, the current study modified the ASSIST 
time frame to refer to the past twelve months rather than the past three months. Cronbach’s alpha 
for each substance involvement score was generally acceptable (above .70) in the current sample. 
Alcohol use screen. The Alcohol Use Disorders Identification Test-Consumption 
(AUDIT-C; Bradley et al., 2007; Bush et al., 1998) is a 3-item screen for at-risk drinking derived 
from the first three items on the AUDIT (Babor, Higgins-Biddle, Saunders, & Monteiro, 2001; 
Saunders, Aasland, Babor, de la Fuente, & Grant, 1993). The AUDIT-C items are each rated on a 
scale from 0 to 4 and address drinking frequency, typical quantity, and frequency of heavy 
drinking (i.e., “five or more drinks on one occasion”) over the past year. Instructions include the 
definition of a “standard drink” (i.e., a 12 oz. beer, 5 oz. glass of wine, or 1.5 oz. shot of liquor; 
National Institute on Alcohol Abuse and Alcoholism, 2005). The AUDIT-C has demonstrated 
strong construct validity across settings, including primary care (Bradley et al., 2007; Campbell 
& Maisto, 2018; Kriston, Hölzel, Weiser, Berner, & Härter, 2008). Prior research in university 
primary care suggests optimal cut-off scores of 5 for females and 7 for males to detect at-risk 
drinking (Campbell & Maisto, 2018). In the current sample, internal consistency of the AUDIT-
C was acceptable, with Cronbach’s alpha equal to 0.80. 
Behavioral health screens. Additional behavioral health concerns that are particularly 
prevalent among college students (i.e., anxiety, depression, sleep difficulties, and posttraumatic 
stress) were screened for using measures designed to be implemented in primary care settings. 
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 Elevated risk for depression, sleep disturbance, and suicidal ideation were screened for 
using the 9-item Patient Health Questionnaire (PHQ-9), a validated measure of depression 
severity developed for use in primary care (Kroenke, Spitzer, & Williams, 2001). Scores of 10 or 
higher indicate positive screens for moderate depression (Kroenke et al., 2001). In the current 
sample, Cronbach’s alpha was 0.84 for the PHQ-9, indicating acceptable internal consistency. 
Based on prior research (MacGregor, Funderburk, Pigeon, & Maisto, 2012; Shepardson 
& Funderburk, 2014), individual items from the PHQ-9 were examined as screeners for sleep 
disturbance (item 3) and suicidal ideation (item 9). Research suggests that the PHQ-9 item 3 
screen for sleep disturbance is a valid alternative to longer sleep questionnaires, with any score 
above 0 indicating a positive screen (MacGregor et al., 2012). The one item screen for suicidal 
ideation is currently used in clinical practice at Syracuse UHS (Shepardson & Funderburk, 2014) 
and is comparable to longer self-report screens (Uebelacker, German, Gaudiano, & Miller, 
2011). Any score above 0 on item 9 was considered a positive screen indicating a need to further 
assess for suicidal ideation (Uebelacker et al., 2011). 
 The Generalized Anxiety Disorder 7-item scale (GAD-7) was developed in primary care 
settings and was used as a screen for increased risk of anxiety disorders (Kroenke, Spitzer, 
Williams, Monahan, & Löwe, 2007; Spitzer, Kroenke, Williams, & Löwe, 2006). A score of 10 
or higher suggests moderate risk for an anxiety disorder and need for further assessment. The 
GAD-7 has demonstrated good internal consistency and construct validity across settings, 
including primary care (Jordan, Shedden-Mora, & Löwe, 2017; Löwe et al., 2008; Zhong et al., 
2015). In the current sample, internal consistency was acceptable (Cronbach’s alpha = 0.86). 
 Elevated risk for posttraumatic stress disorder (PTSD) was screened for via the 4-item 
Primary Care PTSD screen (PC-PTSD; Prins et al., 2004). The PC-PTSD has been used 
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extensively in Department of Veterans Affairs primary care settings to screen for the presence of 
posttraumatic stress symptoms (i.e., re-experiencing, hyper-arousal, avoidance, and numbing), 
with a cut-off score of 3 indicating increased risk for PTSD with a sensitivity of .78 and 
specificity of .87 (Prins et al., 2004). The PC-PTSD has demonstrated sound psychometric 
properties among recent combat veterans as well as veterans seen in primary care (Bliese et al., 
2008; Ouimette, Wade, Prins, & Schohn, 2008). Specifically, the PC-PTSD demonstrated 
diagnostic efficiency equivalent to the 17-item PTSD Checklist (Weathers, Litz, Herman, Huska, 
& Keane, 1993), as well as strong predictive validity for the criterion of a PTSD diagnosis as 
determined by a clinical interview (Bliese et al., 2008; Ouimette et al., 2008). In the current 
sample, internal consistency was acceptable (Cronbach’s alpha = 0.73). In a prior study that 
recruited students who had utilized Syracuse UHS, 20.3% screened positive (with a score of 3 or 
4) on the PC-PTSD (Johnson, Brenner, Campbell, & Maisto, 2018). The PC-PTSD-5, a recent 
update to the PC-PTSD, was not used in the current study because it has yet to be validated 
beyond its original study and has no precedent for use among college student samples (Prins et 
al., 2016). 
 Body mass index. Although unhealthy diet is a leading contributor to preventable disease 
and mortality in the United States (Babor et al., 2004), there is no consensus regarding how best 
to operationalize dietary intake (Jones, 2002; Plotnikoff et al., 2015; Shao et al., 2017). In fact, 
the healthiest diets are characterized by numerous factors that are more complicated than can be 
summarized in a brief screen (Willcox, Willcox, Todoriki, & Suzuki, 2009). However, body 
mass index (BMI) is a commonly used metric in primary care (Lopez-Jimenez & Miranda, 2010) 
and can be used as a proxy measure for dietary intake (Bailey & Ferro-Luzzi, 1995). BMI was 
calculated according to height and weight using the formula: weight [lbs]/ height [inches]2 *703 
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(National Heart, Lung, and Blood Institute, 1998). Height and weight were directly measured 
during the research session. Unhealthy BMI was indicated by a score below 18.5, indicating 
underweight, or 25.0 or higher, indicating overweight or obesity.  
 Demographics. A demographics questionnaire asked participants to report age, gender, 
year in school, GPA, race, ethnicity, and Greek like involvement (i.e., fraternity/sorority 
membership). Given that approximately 20% of students enrolled at SU are international 
students (Syracuse University, n.d.), participants were also asked to indicate whether they speak 
English as a second language (ESL) or English as their first language (non-ESL). 
Data Analyses 
 Data cleaning. Prior to analyses, data distributions were examined for outliers and 
checked for missing data. Variables with skewed or kurtotic distributions were not transformed 
because analyses did not assume normality.  
 Validity and utility of the SUBS. Concurrent validity of the SUBS was examined 
through bivariate nonparametric correlations between the SUBS and the ASSIST. Specifically, 
correlations were examined between the SUBS tobacco score and ASSIST tobacco score, the 
SUBS alcohol score and ASSIST alcohol score, the SUBS illicit drug score and the sum of all 
ASSIST illicit drug scores (i.e., cannabis, cocaine, methamphetamine, inhalants, street sedatives, 
hallucinogens, and street opioids), and the SUBs nonmedical prescription drug score and the sum 
of all ASSIST nonmedical prescription drug scores (i.e., prescriptions stimulants, sedatives, and 
opioids). Concurrent validity of the SUBS alcohol use item was also examined through bivariate 
nonparametric correlations with the AUDIT-C. 
Receiver Operating Characteristic (ROC) curve analyses (Metz, 1978) tested the utility of 
the SUBS for detecting at-risk use of alcohol, tobacco, illicit drugs, and nonmedical prescription 
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drugs. ROC curves plotted the false positive fraction (1 - specificity) against the true positive 
fraction (sensitivity) at each score on the SUBS. The area under the ROC curve (AUC) suggests 
how well the screen differentiates between those who are positive versus those who are negative 
for the criterion of interest (i.e., at-risk use on the ASSIST).  
Reference standards were ASSIST at-risk use, as defined by a score of 11 or more for 
alcohol and a score of 4 or more for all other substances (Humeniuk & World Health 
Organization, 2010). The tobacco and alcohol criteria were based on their respective ASSIST 
scores (Humeniuk et al., 2006). For nonmedical prescription drug use and illicit drug use, 
participants were categorized as at-risk if they met the at-risk criterion for any substance within 
that category. Specifically, the nonmedical prescription drug criterion was based on at-risk use as 
indicated by ASSIST scores for prescription stimulants, prescription sedatives, or prescription 
opioids. The illicit drug criterion was based on at-risk use as indicated by ASSIST scores for 
cannabis, cocaine, methamphetamine, inhalants, street sedatives (e.g., Rohypnol), hallucinogens, 
or street opioids (e.g., heroin). ROC curve analyses were not conducted for concurrent use of 
multiple substances, as there was no measure in the current study that could be used as a 
reference standard for that criterion. 
For any criterion of interest, a cut-off score is defined as the value for which screening at 
or above that score indicates a reasonable likelihood of meeting that criterion. For the SUBS, an 
empirically derived cut-off score functions as an indicator of the point at which an individual 
likely meets the criteria of at-risk substance use, thereby warranting further assessment. Optimal 
cut-off scores were identified based on the SUBS score that maximized combined sensitivity and 
specificity, as indicated by Youden’s Index (J), where 
J = sensitivity + specificity -1; (Youden, 1950). 
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Youden’s Index indicates the diagnostic ability of each possible cut-off score by equally 
weighing specificity and sensitivity. A cut-off score with no diagnostic ability would have a J 
equal to zero, whereas a diagnostically perfect cut-off score would have a J equal to one. In cases 
where sensitivity and specificity cannot both be maximized, sensitivity is prioritized. This is 
because in primary care settings, the risk of failing to detect a potential problem likely outweighs 
the risk associated with providers unnecessarily conducting further assessment and associated 
costs of untreated substance use problems (Bush et al., 1998).  
ROC analyses were also conducted with the sample separated by gender. Specifically, 
ROC curves were plotted for each gender to determine their corresponding diagnostic indices 
(e.g., AUC, sensitivity, specificity) and to determine whether optimal SUBS cut-off scores 
differed according to gender in the current sample. This is based on prior research suggesting 
that higher cut-off scores be used for men than for women on substance use screens (Campbell & 
Maisto, 2018; DeMartini & Carey, 2012; Neumann et al., 2004).  
Comparing SUBS to AUDIT-C. To compare the utility of the SUBS alcohol item to the 
AUDIT-C in detecting at-risk drinking, diagnostic indices of the SUBS alcohol item were 
compared to diagnostic indices of the AUDIT-C (e.g., AUC, specificity, sensitivity). In addition 
to a visual inspection of diagnostic indices, ROC curves were plotted for both screens to 
determine their corresponding AUC values. The difference between the two AUC values was 
compared according to a nonparametric test for dependent ROC curves (DeLong, DeLong, & 
Clarke-Pearson, 1988) using the pROC package (Robin et al., 2011) in R version 3.5.3. 
 Cluster analyses of multiple risk factors. Descriptive statistics were provided to 
illustrate the frequency of positive screening rates and co-occurrence of the risk factors identified 
earlier: substance use (at-risk alcohol, tobacco, illicit drug, and nonmedical prescription drug 
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use), mental health problems (anxiety, depression, sleep difficulties, posttraumatic stress, and 
suicidal ideation), and BMI. Descriptive statistics include positive screening rates for each risk 
factor, as well as the most common combinations of risk factors (see Funderburk, Maisto, & 
Sugarman, 2007). Cluster analyses determined whether and how these risk factors cluster 
together. Cluster analyses function to identify profiles of behaviors (i.e., risk factors) that tend to 
cluster together (McAloney, Graham, Law, & Platt, 2013). More specifically, the Two-Step 
Cluster Analysis procedure in SPSS standardizes and “pre-clusters” the data and then applies a 
hierarchical clustering algorithm to identify groups of participants with similar risk factor 
profiles (Norušis, 2012; Yim & Ramdeen, 2015).  
Within the Two-Step procedure, hierarchical clustering was used to determine the 
number of groups that best represent the underlying structure of the data because the number of 
groups was unknown a priori, therefore precluding use of k-means clustering (Chiu, Fang, 
Chen, Wang, & Jeris, 2001; Yim & Ramdeen, 2015). The number of clusters was automatically 
determined by the Two-Step procedure, which is based on an estimate using the Bayes 
Information Criterion (BIC) that is then refined to determine the optimal number of clusters 
(Chiu et al., 2001). Individual records were each assigned to their closest cluster according to a 
log-likelihood distance measure (SPSS, 2001). The Two-Step procedure is preferred for these 
exploratory analyses because it does not require the number of expected clusters to be 
determined a priori and allows for clustering of both continuous and categorical variables (Chiu 
et al., 2001; Zhang, Ramakrishnan, & Livny, 1996).  
A Priori Power Analyses 
The vast majority of research utilizing ROC curve analyses does not include power 
analyses or a priori estimates of sample size (Bachmann, Puhan, ter Riet, & Bossuyt, 2006). 
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However, formulas for estimating sample size are presented by Hanley and McNeil (1982), with 
which sample size can be determined according to AUC estimates and the proportion expected to 
meet the criteria of interest. For the current analyses, a primary concern was having sufficient 
sample size to accurately discriminate between individuals meeting vs. not meeting the criteria of 
interest, which were assessed one at a time (i.e., one criterion per ROC curve).  
Previous research (McNeely, Strauss, et al., 2015) provided a basis for AUC estimates for 
the SUBS in detecting at-risk use: .74 (nonmedical prescription drug use), .81 (alcohol), .89 
(illicit drugs), and .97 (tobacco use). AUC estimates were comparable (ranging from .74 to .86) 
for detecting elevated risk for SUD (McNeely, Strauss, et al., 2015). Because the AUC describes 
the probability of the SUBS correctly classifying individuals according to whether or not they 
meet the criterion of interest (i.e., at-risk substance use), the null hypothesis was that the SUBS 
would perform no better than chance, as indicated by an AUC = .50. Accordingly, a sample size 
of 100 was expected to allow for adequate power to detect the difference between the lowest 
anticipated AUC (.74) and chance (.50), power = .90 (PASS 15 Power Analysis and Sample Size 
Software, 2017).  
Results 
Data Preparation 
 Missing data and outliers. Missing ASSIST data were replaced with 0 for three cases in 
which items had been skipped but other responses indicated the response was likely “no” 
(represented by a 0). To determine whether replacing this data with 0’s might have biased 
results, analyses were run both with and without the replaced 0’s. Results did not differ, and 
accordingly results are reported with the missing data replaced. 
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 Gender and GPA were missing for one participant each; these missing data were not 
replaced. Six participants had missing data on the PHQ-9 and two had missing data on the PC-
PTSD for which the intended response could not be inferred, and therefore missing data were not 
replaced and were excluded pairwise (not listwise, so that a participant’s data could be included 
on analyses for which complete data were available). No participants were missing data for 
suicidal ideation, anxiety, or BMI. 
 Five participants had missing data for one or more behavioral health screens that could 
not be determined and were thus excluded from analyses. When determining at-risk status for 
behavioral health variables, participants with missing data were included in two instances: 1) if 
the sum of available data exceeded the threshold for at-risk status, or 2) if the sum of available 
data fell far enough below the threshold that it could not exceed that threshold even if the 
missing item were replaced with the maximum possible value for that item. Based on these rules, 
depression at-risk status was determined for 5 out of 6 participants with missing data, 4 of which 
were negative screens and 1 was positive. PTSD at-risk status could also be determined for 1 out 
of 2 participants with missing data; that participant’s status was coded as negative. Two 
participants with missing data (1 depression, 1 PTSD) maintained missing screening status due to 
the sum of available data being below but close to the threshold, such that likely screening status 
could not be determined. Three participants were missing data for sleep problems. Screening 
statuses for sleep problems could not be determined for those 3 participants, namely because 
they were derived from single items on the PHQ-9. 
 No outliers were identified in the data, potentially due to data collection procedures that 
minimized error (i.e., restricting responses to a possible range). 
Descriptive Data 
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Substance use. Substance use variables were summarized for the whole sample (see 
Tables 2 and 3). The mean AUDIT-C score was 3.67 (SD = 2.54). On the SUBS, 74% endorsed 
any past-year heavy drinking, 39% endorsed past-year tobacco use, 56% endorsed past-year 
illicit drug use, 19% endorsed past-year recreational use of prescription drugs, and 51% endorsed 
past-year concurrent use of multiple substances. On the ASSIST, participants screened positive 
for at-risk substance use at the following rates: 39% alcohol, 22% tobacco, 33% illicit drugs, and 
7% nonmedical prescription drugs. As shown in Table 3, the most commonly used substances 
during the past year were alcohol (91%), cannabis (54%), and tobacco (37%). Participants also 
endorsed past-year use of cocaine (13%), prescription stimulants (13%), prescription sedatives 
(7%), and hallucinogens (4%). Almost a third of participants (33%) endorsed past-year nicotine 
use via e-cigarettes (e.g., vaping, “juul”).  
Validity and Utility of the SUBS 
 Construct validity. As expected, bivariate nonparametric correlations between each 
SUBS item and its corresponding ASSIST sum was statistically significant (p < .001). See 
Tables 4 and 5 for correlation coefficients. The SUBS alcohol item was also significantly 
corelated with the AUDIT-C (rs = .736, p <. 001), providing further evidence supporting its 
concurrent validity.  
 Cut-off scores. All AUC values were significantly greater than .50 (p < .01), indicating 
that each SUBS item performed better than chance at categorizing participants according to at-
risk status on the ASSIST (see Table 6). Furthermore, all AUC values were greater than .70, 
indicating adequate discrimination (Hanley & McNeil, 1982); however, the AUC for tobacco use 
was good (greater than .80) and the AUC for illicit drug use was excellent (greater than .90). See 
Tables 7-10 for ROC curve indices for each class of substance. An examination of Youden’s 
  
24 
index indicates optimal cut-off scores of 2 for detecting at-risk alcohol use (see Table 7) and at-
risk illicit drug use (see Table 8). At-risk tobacco and nonmedical prescription drug use were 
detected at the lower optimal cut-off score of 1 (see Tables 9 and 10).  
Comparing Screens for At-Risk Alcohol Use 
AUDIT-C cut-off scores. ROC curves were also generated for the AUDIT-C with the at-
risk alcohol use criterion on the ASSIST. The AUC value for the AUDIT-C detecting at-risk 
alcohol use was significantly greater than .50 (AUC = .812, SE = .042, p < .001). Examination of 
diagnostic indices suggests an optimal cut-off score of 4 on the AUDIT-C (see Table 11).   
Direct comparison of ROC curves. To examine the utility of the AUDIT-C relative to 
the SUBS alcohol item in detecting at-risk drinking, diagnostic indices of the SUBS alcohol item 
were compared to diagnostic indices of the AUDIT-C (e.g., AUC, specificity, sensitivity). AUC 
was higher for the AUDIT-C (AUC = .812, SE = .042) than for the SUBS alcohol item (AUC = 
.740, SE = .05). Delong’s test for two correlated ROC curves was not significant (Z = -1.91, p = 
.055) but did provide trend-level support for the AUDIT-C out-performing the SUBS in 
classifying participants according to the ASSIST criterion of at-risk alcohol use.  
At the optimal cut-off score of 2, the SUBS alcohol item had a sensitivity of .846 and a 
specificity of .623. Relative to the SUBS, the AUDIT-C had somewhat lower sensitivity (.769) 
and greater specificity (.705) at the optimal cut-off score of 4. At their respective optimal cut-off 
scores, Youden’s index was comparable for the SUBS alcohol item (J = .496) and the AUDIT-C 
(J = .474). 
Exploratory Analyses: Demographic Differences  
Gender comparisons. Given the large over-representation of students who were female 
(76.8%), graduate students (43%), and spoke English as a second language (33%), the likelihood 
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of at-risk use on the ASSIST was compared according to those three variables. As demonstrated 
in Table 12, chi square tests suggest that males and females did not differ in their rates of 
ASSIST at-risk use of tobacco, illicit drugs, or nonmedical prescription drugs. There was, 
however, a significant gender difference in rates for ASSIST at-risk alcohol use. Specifically, 
females were more likely to screen positive (44.7% of females) than were males (21.7% of 
males). 
Graduate student status comparisons. Undergraduate students did not significantly 
differ from graduate students in likelihood of a meeting criteria for ASSIST at-risk nonmedical 
prescription drug use and were marginally more likely to screen positive for at-risk tobacco use 
(see Table 13). Compared to graduate students, undergraduates were significantly more likely to 
meet criteria for at-risk alcohol use (47.4% of undergrads vs. 27.9% of grads) and illicit drug use 
(47.4% of undergrads vs. 14.0% of grads).  
Language-based comparisons. As shown in Table 14, students who spoke English as a 
first language (non-ESL) were more likely to meet criteria for ASSIST at-risk alcohol and illicit 
drug use (p < .05) and were marginally more likely to meet criteria for nonmedical prescription 
drugs (p = .054) relative to students whose first language was not English (ESL). Tobacco use 
risk did not differ according to English-language status (p = .70).  
ROC curve analyses with sub-samples. As identified earlier, there were significant 
differences in likelihood of meeting criteria for at-risk alcohol and illicit drug use on the ASSIST 
according to demographic characteristics. Accordingly, when groups differed in these ASSIST 
outcomes, ROC curve analyses were conducted to determine whether SUBS and AUDIT-C cut-
off scores also differed. 
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 SUBS alcohol item by gender, graduate student status, and language. The AUC for the 
SUBS alcohol item classifying according to ASSIST at-risk alcohol use was not significant for 
males (p  = .351; see Table 15). Accordingly, the optimal SUBS alcohol cut-off score was not 
identified for males. The AUC for the SUBS alcohol item was statistically significant for 
females, undergraduates and graduate students, and students who speak English as a first 
language (see Table 15). For these subgroups, Youden’s index suggested an optimal cut-off 
score of 2. For ESL students, the AUC was marginally significant (AUC = .775, p = .053); only 
5 students met the ASSIST at-risk alcohol use criterion and the 28 remaining ESL students did 
not meet the criteria. Youden’s index suggested an optimal cut-off score of 1 for ESL students, 
although this should be considered tentative given the small sample size and marginal statistical 
significance of the AUC. 
 AUDIT-C by gender, graduate student status, and language. The AUC for the AUDIT-
C screen classifying according to the ASSIST at-risk alcohol use was also not significant for 
males (p = .157). AUC values for the remaining subgroups were statistically significant (p < .05; 
see Table 15). Optimal AUDIT-C cut-off scores were: 2 for graduate students and ESL students, 
4 for females, and 5 for undergraduate students and non-ESL students. 
SUBS illicit drug item by graduate student status and language. The AUC values for 
the ROC curve classifying SUBS illicit drug use according to the ASSIST were statistically 
significant for subsamples of undergraduate students, graduate students, ESL students, and non-
ESL students (see Table 15). Optimal SUBS illicit drug cut-off scores were: 2 for undergraduates 
and non-ESL students, and 1 for graduate students and ESL students. 
Exploratory Cluster Analyses: Behavioral Health Risk Factors  
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Combinations of risk factors. In order to describe the occurrence of multiple risk-
factors, positive screening rates were determined using established cut-off scores (as described 
earlier, in Measures). Cut-off scores for the SUBS were based on the results of the current study 
(i.e., 1 for tobacco and nonmedical prescription drug use, 2 for heavy alcohol use and illicit drug 
use). Table 16 provides descriptive information for each behavioral health screen; Table 17 
presents the positive screening rates for each risk factor, as well as cut-off scores used to 
determine the presence of a positive screen. The most common positive screens, endorsed by 
over a third of participants, were sleep difficulties (65%), at-risk alcohol use (56%), unhealthy 
BMI (40%), tobacco use (39%), and illicit drug use (36%). Fourteen percent of participants 
screened positive for suicidal ideation on the PHQ-9. As described earlier (see Procedures), 
participants who screened positive for suicidal ideation were offered a suicide risk assessment. 
No participants endorsed current suicidal ideation with intent or plan, and therefore no 
immediate referrals for crisis services were indicated. 
Table 18 presents the number of positive screens (a.k.a., risk factors) present in this 
sample. The modal number of risk factors was 2, median was 3, and mean was 3.13. Table 19 
presents the combinations of risk factors that occurred more than once. The most prevalent 
individual positive screens (i.e., BMI, sleep, and alcohol) also comprised the most common 
combinations. 
Cluster analyses. Exploratory Two-Step cluster analyses identified a four-group solution 
that represents the underlying structure of the data (i.e., the ten risk factors), illustrated in Table 
20. The Two-Step procedure identified depression and alcohol use as the most important 
variables for differentiating the clusters [Variable Importance (VI) = .90], followed by tobacco 
and illicit drugs (VI = .46), PTSD (VI = .43), recreational prescription drugs (VI = .34), BMI (VI 
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= .28), anxiety (VI = .18), and lastly sleep (VI = .14). Table 21 presents demographic 
information for each cluster. 
Cluster 1 (n = 11) was comprised of students who all screened positive for depression and 
poor sleep, as well as the majority screening positive for suicidal ideation (73%), PTSD (73%), 
illicit drugs (55%), and tobacco (55%). This cluster consisted of all females whose other 
demographics were consistent with the full sample.  
Cluster 2 (n = 22) was defined by illicit drug use (82%), nonmedical prescription drug 
(54.5%), tobacco use (77%), alcohol use (91%), and healthy BMI (0% with unhealthy BMI). 
This group had the youngest mean age (21.4 years) and had the greatest proportion of students in 
Greek life (46%). 
Cluster 3 (n = 31) was defined by at-risk alcohol use (90%) and unhealthy BMI (61%). 
This cluster had a greater proportion of White students (58%) relative to the full sample (43%). 
Cluster 4 (n = 31) can be described as low-risk, overall, with none of these students 
screening positive for at-risk alcohol use, tobacco use, or depression. This cluster consisted of 
the oldest students (m = 25.10, SD = 6.81), the greatest proportion of graduate students (68%), 
and students who were Asian (48%) or ESL (52%). 
Discussion 
 This sample of 100 students recruited from UHS reported levels of substance use 
consistent with national norms (Center for Behavioral Health Statistics and Quality, 2016) and 
endorsed multiple behavioral health risk factors. A majority endorsed past-year use of alcohol, 
and just over half endorsed past-year concurrent use of multiple substances. The prevalence of 
substance use in this sample supports the need for brief screens to detect at-risk substance use 
when students present for primary care services. 
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Results support the construct validity of the SUBS among students from UHS, extending 
its use to university primary care for the first time. Bivariate correlations with the ASSIST 
provide evidence of concurrent validity in support of the construct validity of the SUBS as a 
brief self-administered screen for at-risk use of alcohol, illicit drug use, nonmedical prescription 
drug use, and tobacco use. ROC curves support the utility in the SUBS for detecting at-risk 
substance use. This study replicates and extends the validity of the SUBS from its original use 
with adults in community-based primary care and hospitals in large cities (Han et al., 2017; 
McNeely, Strauss, et al., 2015). Importantly, optimal cut-off scores differ from those suggested 
by these initial validation studies. 
 Optimal cut-off scores on the SUBS vary for different categories of substances. 
Consistent with hypotheses, at-risk use of alcohol and illicit drugs, of which cannabis was most 
prevalent, were indicated by the higher cut-off of 2. This is consistent with prior research on 
single-item screens for substance dependence, which recommends higher cut-offs in order to 
maximize specificity (Saitz et al., 2014). Inconsistent with hypotheses, but consistent with 
previous research with the SUBS (Han et al., 2017; McNeely, Strauss, et al., 2015), the less 
prevalent categories of substances in the current sample (i.e., tobacco, nonmedical prescription 
drugs) were best detected by the lower cut-off score of 1. The only nonmedical prescription 
drugs endorsed in this sample were sedatives and stimulants. Therefore, results suggest that the 
harms of tobacco, prescription sedatives, and prescription stimulants are apparent at lower levels 
of use (i.e., one or two days in the past 12 months), whereas harms from alcohol and cannabis 
use are more specific to more frequent use (three or more days the past 12 months). This may be 
because alcohol and cannabis are the most commonly used substances in this study and in 
college settings, in general (Center for Behavioral Health Statistics and Quality, 2016). 
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Accordingly, a greater portion of students may be able to use alcohol and cannabis infrequently 
without harms (Colby et al., 2009; Fischer et al., 2017).  
A secondary aim of this study was to examine the utility of the AUDIT-C and directly 
compare the AUDIT-C to the SUBS alcohol item to inform screening practices in primary care. 
A lack of statistically significant difference between the AUC for AUDIT-C and SUBS alcohol 
item suggests that these screens are comparable in their ability to detect at-risk alcohol use. At a 
cut-off score of 2, specificity of the SUBS alcohol item is relatively low (.62). As discussed by 
Han and colleagues (2017), such a low specificity may put unnecessary burden on healthcare 
providers, as 38% of low-risk individuals would be incorrectly flagged as at-risk (i.e., false 
positives) and require allocation of resources for further assessment. The specificity of the 
AUDIT-C is somewhat greater, with a specificity of .71 at the cut-off score of 4. In contrast to 
the superior specificity for the AUDIT-C, sensitivity is better for the SUBS alcohol item (.85) 
relative to the AUDIT-C (.77). Accordingly, within university primary care, providers could 
utilize either the SUBS or the AUDIT-C to screen for at-risk alcohol use. If sensitivity is 
prioritized and resources are available for follow-up assessment, then the SUBS would be 
recommended, with the cut-off score of 2. If specificity is prioritized to minimize false positives, 
then the AUDIT-C could be used, due to a lower false positive rate (29%) compared to the SUBS 
alcohol item (38%).  
The advantages of the AUDIT-C should be considered in light of the additional resources 
required for the 3-item screen relative to the advantages of a 4-item screen that also provides 
information on other substances. Thus, the practical utility of the SUBS may outweigh the 
marginally better diagnostic utility of the AUDIT-C. When considering which screen to 
implement in clinical practice, it is important to consider the role of primary care as a potential 
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entry point into behavioral health treatment. Accordingly, quantity of information gained should 
be considered in addition to minor differences in quality (i.e., differences in AUC values). The 
SUBS is clearly superior in terms of breadth of information, given that it screens for tobacco and 
drugs in addition to alcohol. However, a disadvantage of the SUBS alcohol item is its lack of 
depth compared to the AUDIT-C. The AUDIT-C includes items assessing alcohol use frequency, 
quantity, and frequency of heavy drinking; the SUBS alcohol item has only one item and fewer 
response options, providing information solely on frequency of heavy drinking. The current 
study cannot conclude which screen is best for all university primary care settings, as that 
decision should consider the context in which the screen will be used. Contextual factors to 
consider include time available for patients to complete screens, time available for scoring (as 
the AUDIT-C requires a sum score), and availability of providers to follow up with patients who 
screen positive. Another consideration is whether additional screening is taking place, so that 
patient burden and disruption to clinical workflows can be minimized (Shepardson & 
Funderburk, 2014).  
The optimal cut-off score of 4 on the AUDIT-C is unexpectedly low, particularly given 
prior research validating the AUDIT-C that recommended a cut-off of 6 for students recruited 
from UHS (Campbell, 2015), and specified cut-offs of 5 for females and 7 for males in particular 
(Campbell & Maisto, 2018). This difference might be explained by differences in how the at-risk 
drinking reference standard is defined. The current study defined at-risk drinking as exceeding 
predetermined thresholds on the ASSIST, and the prior study defined at-risk drinking as 
exceeding average weekly consumption limits on the Quick Drinking Screen (Sobell et al., 2003) 
or endorsing six or more negative drinking consequences on the Brief Young Adult Alcohol 
Consequences Questionnaire (Kahler, Strong, & Read, 2005). The lower cut-off score in the 
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current study suggests that the ASSIST criterion may be less stringent than criteria used in 
previous research.  
The lower AUDIT-C cut-off score might also be explained by differences in sample 
characteristics, as this sample was older, more racially diverse, and endorsed less heavy drinking 
relative to prior research in college students (Campbell & Maisto, 2018; DeMartini & Carey, 
2012). The identified cut-off score of 4 is consistent with prior research on the AUDIT-C among 
community samples of adults (Bradley et al., 2007; Dawson, Grant, Stinson, & Zhou, 2005), 
suggesting the current sample may more closely resemble community samples than, for example, 
a sample of introductory psychology students (DeMartini & Carey, 2012). It is also possible that 
there was a response bias due to in-person recruitment and data collection used in this study, 
whereas prior research with UHS patients recruited via email and was entirely online (Campbell 
& Maisto, 2018). 
 Interestingly, and in contrast with previous research (Kypri, Langley, & Stephenson, 
2005; Read, Haas, Radomski, Wickham, & Borish, 2016), a greater proportion of females 
screened positive for at-risk alcohol use relative to males. It is unclear why males in this sample 
were less likely to be risky drinkers. Further, the AUC for the SUBS alcohol item was not 
statistically significant for males alone, perhaps due to the small sample of males in the current 
study (n = 23), of whom only 5 met the ASSIST at-risk alcohol use criterion. Accordingly, a cut-
off score for males could not be determined. An optimal SUBS alcohol cut-off score of 2 was 
identified for all other subgroups, with the exception of ESL students (cut-off score = 1). 
Likewise, the AUDIT-C performed differently according to graduate student status, with 
a higher AUDIT-C cut-off score identified for undergraduates compared to graduate students. 
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The cut-off score of 5 for undergraduates was the same as the cut-off score determined for 
females recruited from UHS in previous research (Campbell & Maisto, 2018). 
 The SUBS also performed differently for graduate students and ESL students. For 
graduate students, at-risk illicit drug use was detected at a lower SUBS cut-off score relative to 
undergraduate students. This might be explained by differences in substance use motives and 
norms, perhaps related to developmental differences between undergraduate and graduate 
students. Differences in SUBS cut-off scores for illicit drug use may also reflect differences in 
awareness of substance-related problems. Additionally, it may be that graduate students have 
been using illicit drugs for longer and therefore may be experiencing more consequences related 
to persistent use. Finally, the context of graduate school may be more demanding and therefore 
promote more interference from even infrequent use. Given the paucity of research examining 
substance use among graduate students, these possibilities warrant further empirical testing. 
Lower cut-off scores were also indicated for detecting at-risk alcohol and illicit drug use 
among ESL students. This suggests that any past-year use among these students (as indicated by 
a SUBS score of 1), and not just repeated use, could be considered potentially problematic and 
warrants additional assessment. It could be that some ESL students lack supports and resources 
more readily available to native English speakers. Thus, any substance use may be more likely to 
be problematic due to a lack of resources to buffer against risk. Alternatively, it could be that 
subgroups of students, including ESL students and graduate students, are more aware of and 
sensitive to negative consequences and therefore more likely to endorse higher scores on the 
ASSIST, which would then translate to meeting the criteria for at-risk use with relatively 
infrequent use on the SUBS. 
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 Further research is needed examining these differences given the small sample sizes for 
subgroups and lack of a priori hypotheses, particularly regarding graduate students and ESL 
students. Additional differences may exist for nonmedical prescription drug use and tobacco use, 
but lack of power may have prevented these differences from being detected in the present 
sample. 
This study provides information on positive screening rates for other behavioral health 
risk factors in addition to substance use. Over half the sample screened positive for sleep 
difficulties and at-risk drinking, and over a third screened positive for unhealthy BMI, tobacco 
use, and illicit drug use. The prevalence of multiple behavioral health concerns, combined with 
the need for efficient screening procedures (Funderburk et al., 2018), supports the use of brief 
but comprehensive screening batteries. The SUBS could certainly fit into this type of battery in a 
university primary care setting. There is also preliminary evidence for the validity of a relatively 
brief but also comprehensive screen, the Primary Care Behavioral Health Screen (Pollard, 
Margolis, Niemiec, Salas, & Aatre, 2013), and a 17-item mental health scale in primary care 
settings (Behavioral Health Measure-20; Bryan et al., 2014), although these have not been 
studied in university primary care. The relative benefits of using a comprehensive behavioral 
health questionnaire or a battery comprised of multiple separate screens has yet to be tested 
empirically. 
An examination of combinations of risk factors suggests that the most common 
combinations tended to include at-risk BMI, sleep, and alcohol use. These results support the 
need for brief interventions targeting these behavioral health concerns in primary care. Recent 
reviews suggest there are evidence-based brief interventions for many of the risk factors 
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endorsed in this study, including sleep difficulties, substance use, depression, suicidal ideation, 
and weight management (Funderburk & Shepardson, 2015; Funderburk et al., 2018).  
Exploratory analyses also indicate that behavioral health risk factors cluster together, 
with clusters being primarily defined by depression and other mental health risk factors (Cluster 
1), substance use (Cluster 2), at-risk alcohol use and unhealthy BMI (Cluster 3), and a relative 
lack of risk factors (Cluster 4). These clusters vary in their demographic makeup, with gender, 
graduate student status, Greek life involvement, race, and ESL status varying between groups. 
This suggests that screening and subsequent intervention may be especially needed for certain 
groups of students (e.g., younger, in Greek life). Consistent with demographic differences in at-
risk substance use reported earlier, cluster analyses also suggest lower overall risk among 
students who are graduate students, as well as students who are Asian and ESL. Given the 
descriptive and exploratory nature of these cluster analyses, they should be considered tentative 
and warrant replication in larger samples that more closely resemble the population of students 
utilizing UHS. 
The four clusters identified in the current study are remarkably similar to clusters 
identified in a large multi-site study of community-based primary care patients (n = 1628) that 
used latent class analyses and identified four subgroups, described as Mental Health Risk, 
Substance Use Risk, Dietary Risk, and Lower Risk (Glenn et al., 2018). Likewise, demographics 
of the lower-risk group in the current study are consistent with demographic differences 
described by Glenn and colleagues (2018), who reported patients in their Lower Risk group were 
more likely to be older and more educated relative to those in the Mental Health Risk group. This 
convergence of findings in different populations, using different measures and statistical tests, 
provides support for the validity of this clustering of risk factors. Although preliminary, these 
  
36 
clusters may reflect broader trends in the clustering of behavioral risk factors, and accordingly 
may prove a meaningful avenue for further study. 
It should be noted that the current study defined at-risk BMI as being either above or 
below the healthy BMI range. Of the 40% screening positive for at-risk BMI, the majority were 
overweight or obese; specifically, 28% were overweight, 8% obese, and 4% were underweight. 
Although being underweight or overweight places students at increased risk for medical and 
psychiatric comorbidities, the risk for specific comorbidities varies depending on whether 
individuals are above or below the healthy BMI range (Anderson & Good, 2016; Kass et al., 
2017; Odlaug et al, 2015). Accordingly, it would be informative for future research to examine 
whether clusters differ when at-risk BMI is examined separately according to under/overweight 
status. 
Limitations 
This study’s results should be considered in light of its limitations. For instance, results 
may not generalize to the university as a whole, or to UHS settings at other universities, 
particularly given the differences in demographic characteristics between the study sample, 
students using UHS, and Syracuse University. Unlike prior research conducted at Syracuse UHS 
(Campbell, 2015; Campbell & Maisto, 2018; Funderburk et al., 2012), participant demographics 
did not match those of the university as a whole (Syracuse University, 2016). Relative to prior 
research that recruited from UHS over email (Campbell, 2015), the current sample has a greater 
representation of female, graduate, non-white, and ESL students. Although the reasons for this 
are unknown, there may have been features of the recruitment process that inadvertently 
appealed to these demographics. Accordingly, this study’s results are limited in their 
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generalizability to Syracuse UHS, and also should not be assumed to apply to other UHS settings 
without further research. 
The order in which study measures were administered may also have affected results. 
Participants completed the ASSIST interview first, before moving on to complete the remaining 
self-report items on a computer. Completing the ASSIST first may have primed recall of 
substance use patterns and thereby increased the accuracy of the SUBS. This is consistent with 
how the SUBS was administered in the one other study utilizing the ASSIST and SUBS (Han et 
al., 2017). As recommended by Han and colleagues, it would be valuable for future studies to use 
counterbalancing to test for any potential order effects to determine whether the SUBS performs 
differently when administered before other measures of substance use, particularly since this is 
how the SUBS would be used in primary care settings (i.e., given in the waiting room or at the 
beginning of the appointment). 
An additional limitation relates to the potential impact of social desirability. Previous 
research indicates that college students’ concerns with impression management are inversely 
related to disclosure of harmful substance use (Davis, Thake, & Vilhena, 2010). Accordingly, the 
validity of reported substance use (i.e., on the SUBS, AUDIT-C, and ASSIST) may have been 
influenced by social desirability, particularly for reports of illegal substance use and alcohol use 
among students who are underage and for whom accurate screening would require them to admit 
to illegal activity. Therefore, it is possible that reports of at-risk substance use may be 
underestimated due to under-reporting. 
In contrast, the location of data collection procedures in a research lab that was nearby, 
but separate from, the UHS setting may have encouraged more truthful reports in comparison to 
in-person screening, as participants’ reports were confidential and not shared with their medical 
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providers. The study’s data collection procedures may also attenuate the external validity of 
these findings, given that screening was completed on a computer rather than on paper. In fact, 
research suggests that, relative to paper-based AUDIT-C administration, computer-based 
screening is more likely to result in a positive screen and is less affected by social desirability 
bias (Graham, Goss, Xu, Magid, & Diguiseppi, 2007). Therefore, this study may overstate the 
construct validity of the SUBS and AUDIT-C in primary care due to problems with generalizing 
from a confidential research lab to actual screening procedures in primary care settings.  
Finally, the sample size was insufficient to cross-validate the cluster analyses. Although it 
is promising that results of the cluster analyses resemble those of a large multi-site study in 
community-based primary care (Glenn et al., 2018), replication is needed among a larger sample 
of university primary care patients. 
Future Research Directions 
This is the first study to attempt to extend the validity of the SUBS to university primary 
care. Accordingly, further research is warranted to replicate these findings. There is also room 
for improvement with the SUBS. The low sensitivity of the SUBS alcohol item, in particular, 
supports the need for revisions to reduce the potential for false positives. Given the greater 
variability and specificity of the AUDIT-C relative to the SUBS, both in the current study and in 
previous research (Campbell & Maisto, 2018), the utility of the SUBS might be improved by 
combining the AUDIT-C with the SUBS items for tobacco, illicit drugs, and nonmedical 
prescription drugs. This would result in a 6-item screen that would help to minimize false 
positives for at-risk drinking while also alerting providers to the presence of other at-risk 
substance use. 
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Given the importance of provider buy-in for implementing universal screening 
(Shepardson & Funderburk, 2014), future research should seek provider feedback regarding the 
use and implementation of the SUBS. Provider feedback would also be important to inform how 
lengthy the total screening process can be without interfering with necessary workflows (Byhoff 
et al., 2019). For example, implementation research suggests that a 28-minute behavioral health 
screening tool is not sustainable in community-based primary care (Krist et al., 2014). Within 
UHS, in particular, it is unclear at what point screening procedures would be considered too 
lengthy by providers, and therefore warrants consideration for future research. Feasibility 
research is also warranted to determine whether and how the SUBS could best be integrated into 
existing screening practices within university primary care. 
Inclusion of a fifth SUBS item screening for concurrent use of multiple substances 
represents an important first step toward screening for such use in primary care settings, 
particularly given the increased potential for harm when substances are used concurrently 
(Agosti et al., 2002; Jacobus, Squeglia, Infante, et al., 2015; Meda et al., 2017). ROC curves 
were not generated for the fifth item due to the lack of a reference standard for that criterion. 
Further research examining the validity of this item is warranted, and to determine which cut-off 
score would detect an increased likelihood of risk related to concurrent use of multiple 
substances. 
A strength of the current study is that it examined differences in the utility of the SUBS 
and AUDIT-C among different subgroups of students, including ESL and graduate students. 
Given that lower cut-off scores were indicated for non-native English speakers, future research 
could examine differences in English language fluency, and whether oral administration or 
translating the SUBS to the individual’s primary language might change how it performs. Future 
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research is also needed with a larger sample of males to determine whether and how SUBS cut-
off scores might differ for males. 
The co-occurrence and clustering of risk factors in this sample suggests a need for brief 
interventions targeting multiple risk factors (King et al., 2015; Parekh, Vandelanotte, King, & 
Boyle, 2012). The most prevalent combination of risk factors included at-risk alcohol use, sleep, 
and BMI. There does not appear to be any research examining brief interventions for this 
combination of risk factors. Given the prevalence of these risk factors in the current sample, this 
is an important area for future research. Future research could also identify mechanisms common 
to these risk factors, thereby informing brief interventions that targeting common mechanisms to 
more efficiently effect change across risk factors. For example, mindfulness-based interventions 
are theorized to foster self-regulation, as well as increased awareness of moment-to-moment 
experience (Vago & Silbersweig, 2012). Research suggests that greater mindfulness is associated 
with better psychological and physical health, as well as improved behavioral regulation (Canby, 
Cameron, Calhoun, & Buchanan, 2015; Dvořáková et al., 2017; Keng, Smoski, & Robins, 2011; 
Roberts & Danoff-Burg, 2011). Accordingly, future research could examine whether students 
with multiple risk factors benefit from interventions fostering self-regulation via mindfulness, 
such as Acceptance and Commitment Therapy (Hayes, 2004) or Mindfulness-Based Stress 
Reduction (Kabat-Zinn, 1990). 
The co-occurrence of risk factors also suggests a need to determine whether patients 
benefit more from interventions that are provided concurrently or sequentially, and which risk 
factors should be addressed first or most intensively. For example, addressing sleep first may 
have carry-over effects to improving other behavioral health problems (e.g., Pigeon, Campbell, 
Possemato, & Ouimette, 2013). In the current study, sleep disturbances did not differentiate the 
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clusters and were endorsed by a majority (65%) of participants. Further, sleep disturbances have 
less associated stigma relative to substance use or other behavioral health concerns (Hanschmidt 
et al., 2017). Accordingly, further research might test the effects of a brief intervention for sleep 
as an initial introduction to behavioral health care, potentially as a more acceptable first step that 
could then segue to brief interventions addressing more stigma-laden topics (e.g., depression, 
substance use).  
Future research could also examine whether the identified clusters of risk factors predict 
treatment utilization or other health-related outcomes (Funderburk et al., 2014). Relatedly, UHS 
patients present for a variety of appointment types, which may or may not relate to acute illness. 
For example, patients can utilize UHS for preventative care, STD testing, psychiatric medication 
management, immunizations, or acute illness. Future research could examine whether cluster 
membership predicts differences in how patients utilize university primary care. For instance, are 
clusters equally represented across appointment types, or are individuals from higher-risk 
clusters more likely to utilize certain types of appointments, or at different times? This is an 
under-explored area of research that could inform the implementation of screening across 
different facets of UHS.  
Given the current study’s focus on risk factors, future research might also consider 
screening for protective factors (e.g., social support, resilience, spirituality). Screening for 
protective factors could facilitate a broader, whole-person perspective and set the tone for 
medical appointments incorporating a strengths-based approach rather than being predominantly 
problem-focused (Duncan et al., 2007). 
Conclusions and Clinical Implications 
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This is the first study to provide evidence for the construct validity of a multi-substance 
screen in a university primary care setting. Despite limitations in the representativeness of the 
sample, results provide preliminary support for the use of the SUBS to screen for at-risk 
substance use in this setting, with cut-off scores of 2 for alcohol and illicit drugs, and 1 for 
nonmedical prescription drugs and tobacco. Further research is needed examining its validity 
among subgroups, including males, ESL students, and graduate students. Examining both the 
SUBS and AUDIT-C supports the use of either screen, with the SUBS indicated when resources 
are available to follow up on positive screens for substances in addition to alcohol. A strength of 
this study is its examination of multiple risk factors in university primary care. Results support 
the need for comprehensive screening and combined interventions that maximize the impact on 
multiple risk factors.  
This study has a number of strengths addressing the limitations of previous research on 
screening in university primary care (Campbell, 2015; Campbell & Maisto, 2018). Strengths 
include recruiting directly from the UHS waiting room rather than via email, screening for other 
drugs and behavioral health concerns in addition to alcohol, and using a more comprehensive 
reference standard for at-risk substance use.  
Clinical practice would benefit from consistently using validated screens with cut-off 
scores determined within the population of interest. Implementation will likely require consistent 
educational efforts for primary care providers regarding the use and purpose of screening, 
especially if additional screens are perceived as adding to the burden of usual clinical 
procedures. Ideally, with adequate educational and implementation efforts, consistent screening 
has the potential to improve recognition of at-risk substance use and other behavioral health risk 
factors, thereby reducing the individual and public health impact of behavioral health concerns.   
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Table 1 
Participant Demographic Characteristics 
 % / m (SD) n 
Gender  99 
Female 76.8%  
Male 23.2%  
Other 0.0%  
Age 23.32 (5.56) 100 
Race  100 
White 43.0%  
Asian 34.0%  
Black 8.0%  
Multi-Racial 10.0%  
Other 5.0%  
Ethnicity  100 
Hispanic 12%  
Non-Hispanic 88%  
English as first language?  100 
Yes 67.0%  
No 33.0%  
GPA 3.43 (0.53) 99 
Year in school  100 
Freshman 15.0%  
Sophomore 17.0%  
Junior 13.0%  
Senior 11.0%  
5th-year Senior 1.0%  
Graduate student 43.0%  
Greek Life   100 
No 70.0%  
Yes 30.0%  
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Table 2 
 
Substance Use Screening Information for the Full Sample 
Variable Any past-
year use (%) 
1: 1-2 
days (%) 
2: 3+ 
days (%) 
Mean Mdn SD Min-
Max 
SUBS – Alcohol (4+ drinks) 74 18 56 1.30 2.00 0.86 0-2 
SUBS – Tobacco (any) 39 15 24 0.63 0.00 0.85 0-2 
SUBS – Illicit Drugs (any) 56 20 36 0.92 1.00 0.90 0-2 
SUBS – Rx Drugs (any) 19 11 8 0.27 0.00 0.60 0-2 
SUBS – Concurrent  51 25 26 0.77 1.00 0.84 0-2 
AUDIT-C  90 -- -- 3.67 3.00 2.54 0-10 
 
 
 
 
 
 
 
Table 3 
 
ASSIST Substance Involvement Scores 
ASSIST Variable Any 
Lifetime 
use (%) 
Any Past-
year use 
(%) 
Mean Mdn SD Min-Max 
Alcohol 94 91 9.75 8.00 7.41 0-32 
Tobacco 54 37 3.04 0.00 6.08 0-31 
Cannabis 64 54 5.16 2.00 7.93 0-30 
Prescription Stimulants 18 13 0.65 0.00 2.36 0-19 
Cocaine 15 13 0.69 0.00 2.28 0-14 
Hallucinogens 12 4 0.21 0.00 1.09 0-9 
Prescription Sedatives 11 7 0.68 0.00 3.52 0-29 
Inhalants 3 0 0.00 0.00 0.00 0-0 
Prescription Opioids 3 0 0.00 0.00 0.00 0-0 
Methamphetamine 0 0 0.00 0.00 0.00 0-0 
Street Sedatives 0 0 0.00 0.00 0.00 0-0 
Street Opioids 0 0 0.00 0.00 0.00 0-0 
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Table 4 
 
Nonparametric Correlations Between SUBS Items and ASSIST Sums 
Substance  Spearman’s rho p 
Alcohol .580 < .001 
Tobacco .928 < .001 
Illicit Drugs .878 < .001 
Nonmedical Rx Drugs .769 < .001 
 
 
 
 
 
Table 5 
 
Nonparametric Correlations Among Alcohol Use Screens 
 ASSIST Alcohol  SUBS Alcohol  AUDIT-C 
ASSIST Alcohol Sum 1.00 -- -- 
SUBS Alcohol Item .580 1.00 -- 
AUDIT-C Sum .677 .736 1.00 
Note: All correlations are statistically significant with p < .001. 
 
 
 
 
Table 6 
 
AUC Values for ASSIST At-Risk Criteria 
 
Criterion AUC SE p  95% CI N+ N- 
SUBS Alcohol .740 .050 <.001 .641 - .838 39 61 
SUBS Tobacco .885 .038 <.001 .811 - .960  22 78 
SUBS Rx Drugs .795 .104 .009 .590 - 1.00 7 93 
SUBS Illicit Drugs .914 .028 <.001 .859 - .969  33 67 
Note. N+ indicates positive at-risk status on the ASSIST; N- indicates negative at-risk status on the ASSIST. 
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Table 7 
 
Sensitivity, Specificity, & Youden’s Index for SUBS Alcohol and ASSIST At-Risk 
Criterion 
Cut-off Sensitivity 1-Specificity Specificity Youden's Index 
0 1.000 1.000 .000 .000 
1 .923 .623 .377 .300 
2 .846 .377 .623 .469 
 
 
 
Table 8 
 
Sensitivity, Specificity, & Youden’s Index for SUBS Illicit Drugs and ASSIST At-Risk 
Criterion 
Cut-off Sensitivity 1-Specificity Specificity Youden's Index 
0 1.000 1.000 .000 .000 
1 1.000 .343 .657 .657 
2 .848 .119 .881 .729 
 
 
 
Table 9 
 
Sensitivity, Specificity, & Youden’s Index for SUBS Tobacco and ASSIST At-Risk 
Criterion 
Cut-off Sensitivity 1-Specificity Specificity Youden's Index 
0 1.000 1.000 .000 .000 
1 .955 .231 .769 .724 
2 .682 .115 .885 .566 
 
 
 
Table 10 
 
Sensitivity, Specificity, & Youden’s Index for SUBS Nonmedical Prescription Drug 
Use and ASSIST At-Risk Criterion 
Cut-off Sensitivity 1-Specificity Specificity Youden's Index 
0 1.000 1.000 .000 .000 
1 .714 .151 .849 .564 
2 .429 .054 .946 .375 
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Table 11 
 
Sensitivity, Specificity, & Youden’s Index for AUDIT-C with ASSIST At-Risk Criterion 
Cut-off Sensitivity 1-Specificity Specificity Youden's Index 
0 1.000 1.000 .000 .000 
1 1.000 .836 .164 .164 
2 .974 .574 .426 .401 
3 .897 .459 .541 .438 
4 .769 .295 .705 .474 
5 .667 .213 .787 .454 
6 .487 .164 .836 .323 
7 .308 .033 .967 .275 
8 .179 .016 .984 .163 
9 .051 .000 1.000 .051 
10 .026 .000 1.000 .026 
 
 
 
 
Table 12 
 
Gender Differences in Rates of At-Risk Use on the ASSIST 
 Males Females Combined   
Variable % At-Risk n % At-Risk n % At-Risk c2 p 
Alcohol 21.7 23 44.7 76 39.4 3.91 .048 
Tobacco 26.1 23 21.1 76 22.2 0.26 .611 
Illicit Drugs 26.1 23 35.5 76 33.3 0.71 .400 
Nonmedical Prescription Drugs 0.0 23 9.2 76 7.1 2.28 .131 
  
 
 
 
Table 13 
 
Graduate Student Status Differences in Rates of At-Risk Use on the ASSIST 
 Undergraduate Graduate Combined   
Variable % At-Risk n % At-Risk n % At-Risk c2 p 
Alcohol 47.4 57 27.9 43 39.0 3.90 .048 
Tobacco 28.1 57 14.0 43 22.0 2.85 .092 
Illicit Drugs 47.4 57 14.0 43 33.0 12.38 .000 
Nonmedical Prescription Drugs 10.5 57 2.3 43 7.0 2.53 .112 
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Table 14 
 
English-Language Differences in Rates of At-Risk Use on the ASSIST 
 English as first 
language 
English as 
second language 
Combined   
Variable % At-Risk n % At-Risk n % At-Risk c2 p 
Alcohol 50.7 67 15.2 33 39.0 11.78 .001 
Tobacco 20.9 67 24.2 33 22.0 0.14 .704 
Illicit Drugs 40.3 67 18.2 33 33.0 4.89 .027 
Nonmedical Prescription Drugs 10.4 67 0.0 33 7.0 3.71 .054 
 
 
 
 
 
Table 15 
 
Subgroup AUC Curve Analyses Screening for At-Risk Use on the ASSIST 
Screen Subgroup AUC SE p N+ N- Optimal cut-off 
SUBS Alcohol Males 0.639 0.129 0.351 5 18 n/a 
 Females 0.787 0.054 0.000 34 42 2 
 Undergraduate 0.719 0.068 0.005 27 30 2 
 Graduate 0.708 0.091 0.036 12 31 2 
 English 1st language 0.721 0.064 0.002 34 33 2 
 English 2nd language 0.775 0.086 0.053 5 28 1 
AUDIT-C Males 0.711 0.116 0.157 5 18 n/a 
 Females 0.830 0.046 0.000 34 42 4 
 Undergraduate 0.812 0.056 0.000 27 30 5 
 Graduate 0.804 0.068 0.002 12 31 2 
 English 1st language 0.760 0.058 0.000 34 35 5 
 English 2nd language 0.829 0.073 0.021 5 28 2 
SUBS Illicit Drugs Undergraduate 0.877 0.048 0.000 27 30 2 
 Graduate 0.944 0.035 0.001 6 37 1 
 English 1st language 0.892 0.040 0.000 27 40 2 
 English 2nd language 0.948 0.038 0.001 6 27 1 
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Table 16 
 
Behavioral Health Screen Information 
Variable Mean Mdn SD Min-Max n 
Depression (PHQ-9) 5.77 5.00 4.51 0-22 94 
Suicidal Ideation item 0.15 0.00 0.39 0-2 100 
Sleep item 0.94 1.00 0.93 0-3 97 
Anxiety (GAD-7) 5.80 5.00 4.38 0-18 100 
Posttraumatic Stress (PC-PTSD)  1.11 0.00 1.33 0-4 98 
BMI 24.44 23.31 4.59 16.81-44.41 100 
Note. Reports were based on past 2 weeks (PHQ-9, suicidal ideation item, sleep item, 
GAD-7) and past month (PC-PTSD). 
 
 
 
 
 
 
 
 
Table 17 
 
Rates of Positive Substance Use Screens and Behavioral Health Screens 
Variable Cut-Off Score Positive Screen 
(%) 
N in analyses 
SUBS – Alcohol (4+ drinks) 2 56.0 100 
SUBS – Tobacco (any) 1 39.0 100 
SUBS – Illicit Drugs (any) 2 36.0 100 
SUBS – Nonmedical Rx Drugs (any) 1 19.0 100 
Depression (PHQ-9) 10 14.1 99 
Suicidal Ideation item 1 14.0 100 
Sleep item 1 64.9 97 
Anxiety (GAD-7) 10 17.0 100 
Posttraumatic Stress (PC-PTSD)  3 17.2 99 
BMI < 18.5 or ³ 25 40.0 100 
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Table 18 
 
Number of Risk Factors 
 Frequency Percent Cumulative 
Percent 
0 3 3 3 
1 16 16 19 
2 23 23 42 
3 18 18 60 
4 12 12 72 
5 12 12 84 
6 8 8 92 
7 1 1 93 
9 2 2 95 
Missing 5 5 100 
 
 
 
 
 
Table 19 
 
Combinations of Risk Factors Endorsed by Multiple Participants 
Risk Factor Combination Percent (N = 100) 
BMI only 6.0 
BMI & Sleep 5.0 
Alcohol & Sleep 5.0 
Alcohol, BMI, & Sleep 5.0 
Alcohol, Tobacco, Illicit Drugs, & Sleep 4.0 
Alcohol only 4.0 
Alcohol, Tobacco, BMI, & Sleep 3.0 
Sleep only 3.0 
None 3.0 
Alcohol & Tobacco 2.0 
Alcohol, Tobacco, & BMI 2.0 
Alcohol, Tobacco, & Illicit Drugs 2.0 
Alcohol, Tobacco, Illicit Drugs, Sleep, & Anxiety 2.0 
Alcohol, Tobacco, Illicit Drugs, Rx Drugs, BMI, & Sleep 2.0 
Alcohol, Tobacco, Illicit Drugs, Rx Drugs, PTSD, & Sleep 2.0 
Sleep & PTSD 2.0 
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Table 20 
 
Two Step Cluster Analysis 
Cluster 1 2 3 4 
Size 11.6% (n = 11) 23.2% (n = 22) 32.6% (n = 31) 32.6% (n = 31) 
Variable and positive screen rates within-cluster (sorted by within-cluster importance) 
 Depression 100% Illicit Drugs 81.8% Alcohol 90.3% Alcohol 0% 
 SI 72.7% Rx Drugs 54.5% BMI 61.3% Tobacco 0% 
 PTSD 72.7% Tobacco 77.3% Anxiety 0% Illicit Drugs 12.9% 
 Anxiety 45.5% BMI 0% PTSD 0% Sleep 45.2% 
 Sleep 100% Alcohol 90.9% Illicit Drugs 0% Depression 0% 
 Illicit Drugs 54.5% SI 0% Depression 3.2% Rx Drugs 3.2% 
 Tobacco 54.5% Anxiety 27.3% SI 6.5% BMI 48.4% 
 BMI 27.3% Depression 9.1% Rx Drugs 9.7% PTSD 12.9% 
 Rx Drugs 9.1% Sleep 72.7% Tobacco 41.9% SI 12.9% 
 Alcohol 45.5% PTSD 13.6% Sleep 67.7% Anxiety 16.1% 
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Table 21 
 
Cluster Demographic Characteristics 
Cluster 1 (n=11) 2 (n=22) 3 (n=31) 4 (n=31) Full Sample (N=100) 
% Female 100% 86.4% 61.3% 74.2% 76.8% 
 
Age (M, SD) 22.82 (5.36) 21.36 (2.82) 23.42 (5.75) 25.10 (6.81) 23.32 (5.56) 
 
% Graduate Students 
 
36.4% 27.3% 32.3% 67.7% 43.0% 
 
GPA (M, SD) 3.32 (0.47) 3.47 (0.36) 3.34 (0.74) 3.52 (0.42) 3.43 (0.53) 
 
Race 36.4% Asian 
27.3% White 
18.2% Black 
18.2% Other 
40.9% White 
31.8% Asian 
22.7% Multiracial 
4.5% Other 
58.1% White 
19.4% Asian 
12.9% Black 
6.4% Multiracial 
3.2% Other 
48.4% Asian 
32.3% White 
9.7% Multiracial 
6.5% Black 
3.2% Other 
43.0% White 
34.0% Asian 
10.0% Multiracial 
8.0% Black 
5.0% Other 
 
Ethnicity 9.1% Hispanic 27.3% Hispanic 6.5% Hispanic 9.7% Hispanic 12.0% 
 
% in Greek life 18.2%  45.5% 32.3% 19.4% 30.0% 
 
English as 2nd 
language 
27.3% 22.7% 22.6% 51.6% 33.0% 
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Figure 1. ROC curve for SUBS alcohol item predicting ASSIST at-risk alcohol use. Optimal cut-
off score of 2 is indicated by a circle. The diagonal line indicates the theoretical ROC curve for 
AUC = .50. 
  
 54 
 
 
 
Figure 2. ROC curve for SUBS tobacco item predicting ASSIST at-risk tobacco use. Optimal 
cut-off score of 1 is indicated by a circle. The diagonal line indicates the theoretical ROC curve 
for AUC = .50. 
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Figure 3. ROC curve for SUBS illicit drug item predicting ASSIST at-risk illicit drug use. 
Optimal cut-off score of 2 is indicated by a circle. The diagonal line indicates the theoretical 
ROC curve for AUC = .50. 
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Figure 4. ROC curve for SUBS nonmedical prescription drug item predicting ASSIST at-risk 
nonmedical prescription drug use. Optimal cut-off score of 1 is indicated by a circle. The 
diagonal line indicates the theoretical ROC curve for AUC = .50. 
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Figure 5. ROC curve for AUDIT-C predicting ASSIST at-risk alcohol use. Optimal cut-off score 
of 4 is indicated by a circle. The diagonal line indicates the theoretical ROC curve for AUC = 
.50. 
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Figure 6. ROC curves for SUBS alcohol item and AUDIT-C predicting ASSIST at-risk alcohol 
use.  
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Appendix A. 
Substance Use Brief Screen (SUBS) 
 
 
The Substance Use Brief Screen. Reprinted from McNeely, Strauss, et al. (2015), with 
permission from Elsevier. 
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Appendix B. 
Modified 5-Item Substance Use Brief Screen (SUBS) 
 
Instruction: Please check one box Ö  for each question 
Three or 
more days 
in the past 
12 months 
One or 
two days 
in the past 
12 months 
Never in 
the past 
12 
months 
 
1. In the past 12 months, on how many days did you use… 
Tobacco? 
 
   
 
2. In the past 12 months, on how many days did you have…    
4 or more alcoholic drinks in a day, including wine or 
beer? 
 
   
Note: Consider a “drink” to be a can or bottle of beer (12 ounces), a glass of wine (5 ounces), a wine 
cooler (12 ounces) or a shot of hard liquor like gin, vodka or whiskey (1.5 ounces). 
 
3. In the past 12 months, on how many days did you use…    
any Illegal Drug, including marijuana? 
   
 
4. In the past 12 months, on how many days did you use…   
any Prescription Medications “recreationally” (just for 
the feeling, or using more than prescribed)? 
   
Note: “Recreationally” means taking medications just for the feeling or experience they cause, to get 
high, or taking them more often or at higher doses than prescribed. Prescription Medications are those 
that are prescribed to you or to someone else.  
 
5. In the past 12 months, on how many days did you use… 
more than one of the above substances on the same 
occasion (for example, using marijuana while drinking 
alcohol)? 
   
Please indicate which type of substances were used within the same occasion in the past year: 
  Tobacco 
  Alcohol 
  Illegal drug 
  Prescription medication used recreationally 
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Appendix C. 
 
ASSIST Structured Interview  
(modified to differentiate nonmedical use of prescription stimulants, sedatives, and opioids)  
 
 
Introduction (Please read to patient):  
 
Thank you for agreeing to take part in this brief interview about alcohol, tobacco products and 
other drugs. I am going to ask you some questions about your experience of using these 
substances across your lifetime and in the past twelve months. These substances can be smoked, 
swallowed, snorted, inhaled, injected, or taken in the form of pills (show drug card). 
 
Some of the substances listed may be prescribed by a doctor (like amphetamines, sedatives, pain 
medications). For this interview, we will not record medications that are used as prescribed by 
your doctor. However, if you have taken such medications for reasons other than prescription, or 
taken them more frequently or at higher doses than prescribed, please let me know. While we are 
also interested in knowing about your use of various illicit drugs, please be assured that 
information on such use will be treated as strictly confidential.  
 
Note: before asking questions, give ASSIST response card to patient. 
 
Question 1 
In your life, which of the following substances have you ever used? (NON-
MEDICAL USE ONLY) 
No Yes 
a. Tobacco products (cigarettes, chewing tobacco, cigars, etc.) 0 3 
b. Alcoholic beverages (beer, wine, spirits, etc.) 0 3 
c. Cannabis (marijuana, pot, grass, hash, etc.) 0 3 
d. Cocaine (coke, crack, etc.) 0 3 
e. Prescription stimulants (Ritalin, Concerta, Dexedrine, Adderall, diet pills, etc.) 0 3 
f. Methamphetamine (speed, crystal meth, ice, etc.) 0 3 
g. Inhalants (nitrous oxide, glue, gas, paint thinner, etc.) 0 3 
h. Prescription sedatives or sleeping pills (Xanax, Valium, Ativan, Klonopin, Librium, 
Ambien, Lunesta, etc.) 
0 3 
i. Street sedatives (GHB, Rohypnol, roofies, Seconal, phenobarbital, etc.) 0 3 
j. Hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.) 0 3 
k. Street opioids (heroin, opium, etc.) 0 3 
l. Prescription opioids (fentanyl, oxycodone [OxyContin, Percocet], hydrocodone 
[Vicodin], methadone, buprenorphine, etc.) 
0 3 
m. Other – specify: 0 3 
 
If “No” to all items, stop interview. 
If “Yes” to any of these items, ask question 2 for each substance ever used. 
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Question 2 
 
If “Never” to all items in Question 2, skip to Question 6. 
 
If any substances in Question 2 were used in the previous twelve months, continue with 
Questions 3, 4 & 5 for each substance used.  
 
Question 3 
In the past twelve months, how often have you used the 
substances you mentioned (FIRST DRUG, SECOND 
DRUG, ETC)? 
Never Once or 
Twice 
Monthly Weekly Daily or 
Almost 
Daily 
a. Tobacco products (cigarettes, chewing tobacco, cigars, 
etc.) 
0 2 3 4 6 
b. Alcoholic beverages (beer, wine, spirits, etc.) 0 2 3 4 6 
c. Cannabis (marijuana, pot, grass, hash, etc.) 0 2 3 4 6 
d. Cocaine (coke, crack, etc.) 0 2 3 4 6 
e. Prescription stimulants (Ritalin, Concerta, Dexedrine, 
Adderall, diet pills, etc.) 
0 2 3 4 6 
f. Methamphetamine (speed, crystal meth, ice, etc.) 0 2 3 4 6 
g. Inhalants (nitrous oxide, glue, gas, paint thinner, etc.) 0 2 3 4 6 
h. Prescription sedatives or sleeping pills (Xanax, Valium, 
Ativan, Klonopin, Librium, Ambien, Lunesta, etc.) 
0 2 3 4 6 
i. Street sedatives (GHB, Rohypnol, roofies, Seconal, 
phenobarbital, etc.) 
0 2 3 4 6 
j. Hallucinogens (LSD, acid, mushrooms, PCP, Special K, 
ecstasy, etc.) 
0 2 3 4 6 
k. Street opioids (heroin, opium, etc.) 0 2 3 4 6 
l. Prescription opioids (fentanyl, oxycodone [OxyContin, 
Percocet], hydrocodone [Vicodin], methadone, 
buprenorphine, etc.) 
0 2 3 4 6 
m. Other – specify: 0 2 3 4 6 
During the past twelve months, how often have you had a 
strong desire or urge to use (FIRST DRUG, SECOND 
DRUG, ETC)? 
Never Once or 
Twice 
Monthly Weekly Daily or 
Almost 
Daily 
a. Tobacco products (cigarettes, chewing tobacco, cigars, 
etc.) 
0 3 4 5 6 
b. Alcoholic beverages (beer, wine, spirits, etc.) 0 3 4 5 6 
c. Cannabis (marijuana, pot, grass, hash, etc.) 0 3 4 5 6 
d. Cocaine (coke, crack, etc.) 0 3 4 5 6 
e. Prescription stimulants (Ritalin, Concerta, Dexedrine, 
Adderall, diet pills, etc.) 
0 3 4 5 6 
f. Methamphetamine (speed, crystal meth, ice, etc.) 0 3 4 5 6 
g. Inhalants (nitrous oxide, glue, gas, paint thinner, etc.) 0 3 4 5 6 
h. Prescription sedatives or sleeping pills (Xanax, Valium, 
Ativan, Klonopin, Librium, Ambien, Lunesta, etc.) 
0 3 4 5 6 
i. Street sedatives (GHB, Rohypnol, roofies, Seconal, 
phenobarbital, etc.) 
0 3 4 5 6 
j. Hallucinogens (LSD, acid, mushrooms, PCP, Special K, 
ecstasy, etc.) 
0 3 4 5 6 
k. Street opioids (heroin, opium, etc.) 0 3 4 5 6 
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Question 4 
 
Question 5 
l. Prescription opioids (fentanyl, oxycodone [OxyContin, 
Percocet], hydrocodone [Vicodin], methadone, 
buprenorphine, etc.) 
0 3 4 5 6 
m. Other – specify: 0 3 4 5 6 
During the past twelve months, how often has your use of 
(FIRST DRUG, SECOND DRUG, ETC) led to health, 
social, legal, or financial problems? 
Never Once or 
Twice 
Monthly Weekly Daily or 
Almost 
Daily 
a. Tobacco products (cigarettes, chewing tobacco, cigars, 
etc.) 
0 4 5 6 7 
b. Alcoholic beverages (beer, wine, spirits, etc.) 0 4 5 6 7 
c. Cannabis (marijuana, pot, grass, hash, etc.) 0 4 5 6 7 
d. Cocaine (coke, crack, etc.) 0 4 5 6 7 
e. Prescription stimulants (Ritalin, Concerta, Dexedrine, 
Adderall, diet pills, etc.) 
0 4 5 6 7 
f. Methamphetamine (speed, crystal meth, ice, etc.) 0 4 5 6 7 
g. Inhalants (nitrous oxide, glue, gas, paint thinner, etc.) 0 4 5 6 7 
h. Prescription sedatives or sleeping pills (Xanax, Valium, 
Ativan, Klonopin, Librium, Ambien, Lunesta, etc.) 
0 4 5 6 7 
i. Street sedatives (GHB, Rohypnol, roofies, Seconal, 
phenobarbital, etc.) 
0 4 5 6 7 
j. Hallucinogens (LSD, acid, mushrooms, PCP, Special K, 
ecstasy, etc.) 
0 4 5 6 7 
k. Street opioids (heroin, opium, etc.) 0 4 5 6 7 
l. Prescription opioids (fentanyl, oxycodone [OxyContin, 
Percocet], hydrocodone [Vicodin], methadone, 
buprenorphine, etc.) 
0 4 5 6 7 
m. Other – specify: 0 4 5 6 7 
During the past twelve months, how often have you failed 
to do what was normally expected of you because of your 
use of (FIRST DRUG, SECOND DRUG, ETC)? 
Never Once or 
Twice 
Monthly Weekly Daily or 
Almost 
Daily 
a. Tobacco products (cigarettes, chewing tobacco, cigars, 
etc.) 
0 n/a n/a n/a n/a 
b. Alcoholic beverages (beer, wine, spirits, etc.) 0 5 6 7 8 
c. Cannabis (marijuana, pot, grass, hash, etc.) 0 5 6 7 8 
d. Cocaine (coke, crack, etc.) 0 5 6 7 8 
e. Prescription stimulants (Ritalin, Concerta, Dexedrine, 
Adderall, diet pills, etc.) 
0 5 6 7 8 
f. Methamphetamine (speed, crystal meth, ice, etc.) 0 5 6 7 8 
g. Inhalants (nitrous oxide, glue, gas, paint thinner, etc.) 0 5 6 7 8 
h. Prescription sedatives or sleeping pills (Xanax, Valium, 
Ativan, Klonopin, Librium, Ambien, Lunesta, etc.) 
0 5 6 7 8 
i. Street sedatives (GHB, Rohypnol, roofies, Seconal, 
phenobarbital, etc.) 
0 5 6 7 8 
j. Hallucinogens (LSD, acid, mushrooms, PCP, Special K, 
ecstasy, etc.) 
0 5 6 7 8 
k. Street opioids (heroin, opium, etc.) 0 5 6 7 8 
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Ask question 6 & 7 for all substances ever used (i.e. those endorsed in Question 1) 
 
Question 6 
 
Question 7 
l. Prescription opioids (fentanyl, oxycodone [OxyContin, 
Percocet], hydrocodone [Vicodin], methadone, 
buprenorphine, etc.) 
0 5 6 7 8 
m. Other – specify: 0 5 6 7 8 
Has a friend or relative or anyone else ever expressed 
concern about your use of (FIRST DRUG, SECOND 
DRUG, ETC.)? 
No, Never Yes, in the past 12 
months 
Yes, but not in the 
past 12 months 
a. Tobacco products (cigarettes, chewing tobacco, cigars, 
etc.) 
0 6 3 
b. Alcoholic beverages (beer, wine, spirits, etc.) 0 6 3 
c. Cannabis (marijuana, pot, grass, hash, etc.) 0 6 3 
d. Cocaine (coke, crack, etc.) 0 6 3 
e. Prescription stimulants (Ritalin, Concerta, Dexedrine, 
Adderall, diet pills, etc.) 
0 6 3 
f. Methamphetamine (speed, crystal meth, ice, etc.) 0 6 3 
g. Inhalants (nitrous oxide, glue, gas, paint thinner, etc.) 0 6 3 
h. Prescription sedatives or sleeping pills (Xanax, Valium, 
Ativan, Klonopin, Librium, Ambien, Lunesta, etc.) 
0 6 3 
i. Street sedatives (GHB, Rohypnol, roofies, Seconal, 
phenobarbital, etc.) 
0 6 3 
j. Hallucinogens (LSD, acid, mushrooms, PCP, Special K, 
ecstasy, etc.) 
0 6 3 
k. Street opioids (heroin, opium, etc.) 0 6 3 
l. Prescription opioids (fentanyl, oxycodone [OxyContin, 
Percocet], hydrocodone [Vicodin], methadone, 
buprenorphine, etc.) 
0 6 3 
m. Other – specify: 0 6 3 
Have you ever tried and failed to control, cut down or 
stop using (FIRST DRUG, SECOND DRUG, ETC.)? 
No, Never Yes, in the past 12 
months 
Yes, but not in the 
past 12 months 
a. Tobacco products (cigarettes, chewing tobacco, cigars, 
etc.) 
0 6 3 
b. Alcoholic beverages (beer, wine, spirits, etc.) 0 6 3 
c. Cannabis (marijuana, pot, grass, hash, etc.) 0 6 3 
d. Cocaine (coke, crack, etc.) 0 6 3 
e. Prescription stimulants (Ritalin, Concerta, Dexedrine, 
Adderall, diet pills, etc.) 
0 6 3 
f. Methamphetamine (speed, crystal meth, ice, etc.) 0 6 3 
g. Inhalants (nitrous oxide, glue, gas, paint thinner, etc.) 0 6 3 
h. Prescription sedatives or sleeping pills (Xanax, Valium, 
Ativan, Klonopin, Librium, Ambien, Lunesta, etc.) 
0 6 3 
i. Street sedatives (GHB, Rohypnol, roofies, Seconal, 
phenobarbital, etc.) 
0 6 3 
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Question 8 
 
 
How to calculate a specific substance involvement score: 
For each substance (labelled ‘a’ to ‘l’), add up the scores for questions 2 through 7, inclusive. For 
tobacco (substance ‘a’), question 5 is not rated and excluded from the total score. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ali, R., Awwad, E., Babor, T. F., Bradley, F., Butau, T., Farrell, M., … Vendetti, J. (2002). The 
Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Development, 
reliability and feasibility. Addiction, 97(9), 1183–1194. https://doi.org/10.1046/j.1360-
0443.2002.00185.x 
Humeniuk, R., & World Health Organization. (2010). The Alcohol, smoking and substance 
involvement screening test (ASSIST): Manual for use in primary care. Geneva: World 
Health Organization. 
National Institute on Drug Abuse. (2009). Resource guide: Screening for drug use in general 
medical settings. Retrieved from https://www.drugabuse.gov/publications/resource-
guide/preface 
 
  
j. Hallucinogens (LSD, acid, mushrooms, PCP, Special K, 
ecstasy, etc.) 
0 6 3 
k. Street opioids (heroin, opium, etc.) 0 6 3 
l. Prescription opioids (fentanyl, oxycodone [OxyContin, 
Percocet], hydrocodone [Vicodin], methadone, 
buprenorphine, etc.) 
0 6 3 
m. Other – specify: 0 6 3 
 No, Never Yes, in the past 12 
months 
Yes, but not in the 
past 12 months 
Have you ever used any drug by injection? 
(non-medical use only) 
0 2 1 
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Appendix D. 
Alcohol Use Disorders Identification Test – Consumption (AUDIT-C) 
 
Think about your drinking over the past year.  Please circle the response that represents the best 
answer for you. 
 
1 standard drink is equal to: 
Beer or wine coolers: 
12 oz. 
Wine: 
5 oz. 
Hard Liquor (shot): 
1.5 oz. 
 
1. How often do you have a drink containing alcohol? 
0) Never 
1) Monthly or less 
2) 2-4 times a month 
3) 2-3 times a week 
4) 4 or more times a week 
 
2. How many drinks containing alcohol do you have on a typical day when you are 
drinking?  
0) 1 or 2 
1) 3 or 4 
2) 5 or 6 
3) 7 to 9 
4) 10 or more 
 
3. How often do you have five or more drinks on one occasion? 
0) Never 
1) Less than monthly 
2) Monthly 
3) Weekly 
4) Daily or almost daily 
 
 
 
 
 
 
 
 
 
Bush, K., Kivlahan, D. R., McDonell, M. B., Fihn, S. D., & Bradley, K. A. (1998). The AUDIT 
alcohol consumption questions (AUDIT-C): An effective brief screening test for problem 
drinking. Archives of Internal Medicine, 158(16), 1789–1795. 
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Appendix E. 
 
PHQ-9 
 
Over the past 2 weeks, how often have you been bothered by any of the following problems:  
  
 Not at all Several 
days 
More than 
half the days 
Nearly 
every day 
1. Little interest or pleasure in 
doing things      0 1 2 3 
2. Feeling down, depressed, or 
hopeless 0 1 2 3 
3. Trouble falling or staying asleep, 
or sleeping too much 0 1 2 3 
4. Feeling tired or having little 
energy 0 1 2 3 
5. Poor appetite or overeating 0 1 2 3 
6. Feeling bad about yourself – or 
that you re a failure or have let 
yourself or your family down 
0 1 2 3 
7. Trouble concentrating on things, 
such as reading the newspaper or 
watching television 
0 1 2 3 
8. Moving or speaking so slowly 
that other people could have 
noticed. Or the opposite – being 
so fidgety or restless that you 
have been moving around a lot 
more than usual 
0 1 2 3 
9. Thought that you would be better 
off dead, or of hurting yourself in 
some way 
0 1 2 3 
 
 
If you checked off any problems, how difficult have 
these problems made it for you to do your work, take 
care of things at home, or get along with other 
people? 
 
Not difficult at all     _____ 
Somewhat difficult   _____ 
Very difficult            _____ 
Extremely difficult   _____ 
 
 
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief 
depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. 
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Appendix F. 
 
Generalized Anxiety Disorder 7-item scale (GAD-7) 
 
Over the last 2 weeks, how often have you 
been bothered by the following problems?  
Not at all Several 
days 
More 
than half 
the days 
Nearly 
every day 
1. Feeling nervous, anxious, or on edge  
0 1 2 3 
2. Not being able to stop or control 
worrying  0 1 2 3 
3. Worrying too much about different 
things  0 1 2 3 
4. Trouble relaxing  
0 1 2 3 
5. Being so restless that it is hard to sit still  
0 1 2 3 
6. Becoming easily annoyed or irritable  
0 1 2 3 
7. Feeling afraid as if something awful 
might happen  0 1 2 3 
 
 
 
If you checked off any problems, how difficult have 
these made it for you to do your work, take care of 
things at home, or get along with other people? 
 
Not difficult at all     _____ 
Somewhat difficult   _____ 
Very difficult            _____ 
Extremely difficult   _____ 
 
 
 
 
 
 
 
 
 
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for 
assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 
166(10), 1092–1097. https://doi.org/10.1001/archinte.166.10.1092 
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Appendix G. 
 
Primary Care PTSD Screen (PC-PTSD) 
 
 
In your life, have you ever had any experience that was so frightening, horrible, or upsetting that, 
in the past month, you... 
 
1. Have had nightmares about it or thought about it when you did not want to?  
 YES / NO 
 
2. Tried hard not to think about it or went out of your way to avoid situations that reminded you 
of it? 
 YES / NO 
 
3. Were constantly on guard, watchful, or easily startled? 
 YES / NO 
 
4. Felt numb or detached from others, activities, or your surroundings?  
 YES / NO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prins, A., Ouimette, P., Kimerling, R., Cameron, R. P., Hugelshofer, D. S., Shaw-Hegwer, J., 
Thrailkill, A., Gusman, F.D., Sheikh, J. I. (2003). The primary care PTSD screen (PC-
PTSD): Development and operating characteristics. Primary Care Psychiatry, 9, 9-14.  
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Appendix H. 
 
Demographics Questionnaire 
 
Please provide the following information to help us learn more about you.  
 
1. What is your current age? _______  
 
2. What is your gender? 
Male (1) 
Female (2) 
Other (3)  
(If Other) Please specify gender: __________ 
 
3. What year are you in your college career? (If you are a graduate student, select last 
option.) 
1st (1) 
2nd (2) 
3rd (3) 
4th (4) 
5th or higher (5) 
graduate student (6) 
 
4. What is your current/approximate GPA? _______ 
 
5. What racial group(s) best describe(s) you? Select all that apply. 
White (1) 
Black or African-American (2) 
Asian (3) 
American Indian or Alaska Native (4) 
Native Hawaiian or Other Pacific Islander (5) 
Other (6) 
(If Other) Please specify race: __________ 
 
6. Do you identify as Hispanic, Latino, or Spanish?  
Yes (1) 
No (0) 
 
7. Is English your first language? 
Yes (1) 
No (0) 
 
8. Are you a current member of a fraternity or sorority? 
_______ Not a member (0) 
_______ Yes, new member, not yet initiated (1) 
_______ Yes, initiated member (2) 
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